ZAK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| A5A3E0 | T949 | Sugiyama | POTEF A26C1B | TVAsSSSLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O00151 | T80 | Sugiyama | PDLIM1 CLIM1 CLP36 | NMTHLEAQNRIKGCTDNLtLtVARsEHKVWsPLVtEEGKRH |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00267 | T709 | Sugiyama | SUPT5H SPT5 SPT5H | GGSGGMSRGRGRRDNELIGQtVRISQGPYKGYIGVVKDATE |
| O00273 | S302 | Sugiyama | DFFA DFF1 DFF45 H13 | TETVQEACERELALRLQQtQsLHsLRsIsAsKAsPPGDLQN |
| O14950 | T160 | Sugiyama | MYL12B MRLC2 MYLC2B | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| O15371 | T49 | Sugiyama | EIF3D EIF3S7 | PyQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQY |
| O43290 | T430 | Sugiyama | SART1 | RKKEKEVVVRADDLLPLGDQtQDGDFGsRLRGRGRRRVsEV |
| O43390 | T137 | Sugiyama | HNRNPR HNRPR | ESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O43390 | T141 | Sugiyama | HNRNPR HNRPR | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGVQP |
| O43423 | T101 | Sugiyama | ANP32CP PP32R1 | EKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCEV |
| O43707 | T443 | Sugiyama | ACTN4 | sIHEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDL |
| O43707 | T445 | Sugiyama | ACTN4 | HEAWtDGKEAMLKHRDyEtAtLsDIKALIRKHEAFEsDLAA |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O43852 | T89 | Sugiyama | CALU | sKERLGKIVSKIDGDKDGFVtVDELKDWIKFAQKRWIyEDV |
| O60231 | T110 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | LLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRKHLRK |
| O60361 | S107 | Sugiyama | NME2P1 | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDY |
| O60361 | S110 | Sugiyama | NME2P1 | RGDFCIQVGRNIIHGsDsVKsAEKEISLRFKPEELVDYKSC |
| O60506 | T134 | Sugiyama | SYNCRIP HNRPQ NSAP1 | DSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYS |
| O60506 | T138 | Sugiyama | SYNCRIP HNRPQ NSAP1 | GPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVYSGQQP |
| O60739 | T46 | Sugiyama | EIF1B | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | S196 | Sugiyama | EIF5B IF2 KIAA0741 | ERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGPNIEsGN |
| O60841 | T78 | Sugiyama | EIF5B IF2 KIAA0741 | ILKELEELsLEAQGIKADREtVAVKPTENNEEEFtsKDKKK |
| O60927 | T88 | Sugiyama | PPP1R11 HCGV TCTE5 | RAFGEsstEsDEEEEEGCGHtHCVRGHRKGRRRAtLGPtPt |
| O75347 | S103 | Sugiyama | TBCA | ENEKDLEEAEEyKEARLVLDsVKLEA_______________ |
| O75533 | S322 | Sugiyama | SF3B1 SAP155 | DtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsKRKsRWDEtP |
| O75533 | T316 | Sugiyama | SF3B1 SAP155 | tPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsKRKs |
| O75821 | S189 | Sugiyama | EIF3G EIF3S4 | CPYKDtLGPMQKELAEQLGLstGEKEKLPGELEPVQAtQNK |
| O75822 | T33 | Sugiyama | EIF3J EIF3S1 PRO0391 | sWDADAFsVEDPVRKVGGGGtAGGDRWEGEDEDEDVKDNWD |
| O95218 | T50 | Sugiyama | ZRANB2 ZIS ZNF265 | SCNRCGREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQ |
| O95218 | T55 | Sugiyama | ZRANB2 ZIS ZNF265 | GREKTTEAKMMKAGGtEIGKtLAEKSRGLFsANDWQCKTCs |
| O95626 | T105 | Sugiyama | ANP32D PP32R2 | EKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCEV |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95757 | S599 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | sIDLPIQssLCRQLGQDLLNsyIENEGKMIMQDKLEKERND |
| O96017 | T68 | GPS6|EPSD|PSP | CHEK2 CDS1 CHK2 RAD53 | NSsQSSHSSSGTLSsLETVStQELYsIPEDQEPEDQEPEEP |
| P00338 | S167 | Sugiyama | LDHA PIG19 | AWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVHPLSCHG |
| P00338 | T322 | Sugiyama | LDHA PIG19 | DLVKVTLtsEEEARLKKsADtLWGIQKELQF__________ |
| P00558 | S393 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GGDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDA |
| P00558 | S399 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | CCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDALsNI__ |
| P00558 | T369 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | ARGTKALMDEVVKAtsRGCItIIGGGDtAtCCAKWNtEDKV |
| P00558 | T378 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EVVKAtsRGCItIIGGGDtAtCCAKWNtEDKVsHVstGGGA |
| P00558 | T394 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | GDtAtCCAKWNtEDKVsHVstGGGAsLELLEGKVLPGVDAL |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P04040 | S517 | Sugiyama | CAT | LDKYNAEKPKNAIHtFVQsGsHLAAREKANL__________ |
| P04040 | T511 | Sugiyama | CAT | SHIQALLDKYNAEKPKNAIHtFVQsGsHLAAREKANL____ |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T49 | Sugiyama | ALDOA ALDA | GILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtADDR |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04083 | T172 | Sugiyama | ANXA1 ANX1 LPC1 | INRVYREELKRDLAKDItsDtsGDFRNALLsLAKGDRsEDF |
| P04083 | T223 | Sugiyama | ANXA1 ANX1 LPC1 | ARALyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKY |
| P04083 | T226 | Sugiyama | ANXA1 ANX1 LPC1 | LyEAGERRKGtDVNVFNtILttRSyPQLRRVFQKYTKYSKH |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | S321 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsKE______ |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T246 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | GKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKVVKQAS |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T180 | Sugiyama | HSPB1 HSP27 HSP28 | EGtLTVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsD |
| P04792 | T184 | Sugiyama | HSPB1 HSP27 HSP28 | TVEAPMPKLAtQsNEItIPVtFEsRAQLGGPEAAKsDETAA |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S29 | Sugiyama | RPLP2 D11S2243E RPP2 | LAALGGNssPsAKDIKKILDsVGIEADDDRLNKVIsELNGK |
| P05455 | S325 | Sugiyama | SSB | VLEGEVEKEALKKIIEDQQEsLNKWKSKGRRFKGKGKGNKA |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P05787 | S410 | Sugiyama | KRT8 CYK8 | TYRKLLEGEESRLEsGMQNMsIHtKTTSGYAGGLSSAYGGL |
| P06733 | S349 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | AKAVNEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMV |
| P06733 | S353 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NEKsCNCLLLKVNQIGsVTEsLQACKLAQANGWGVMVsHRs |
| P06733 | S37 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | NPtVEVDLFtsKGLFRAAVPsGAstGIyEALELRDNDKtRY |
| P06733 | T100 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | KKLNVtEQEKIDKLMIEMDGtENKsKFGANAILGVsLAVCK |
| P06733 | T19 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | __MSILKIHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGA |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P06733 | T26 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | IHAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEA |
| P06748 | S137 | Sugiyama | NPM1 NPM | VAVEEDAEsEDEEEEDVKLLsIsGKRsAPGGGsKVPQKKVK |
| P07195 | S168 | Sugiyama | LDHB | TWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIHPSSCHG |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | S393 | Sugiyama | PGK2 PGKB | GGDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEA |
| P07205 | S399 | Sugiyama | PGK2 PGKB | CCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEALSNM__ |
| P07205 | T394 | Sugiyama | PGK2 PGKB | GDTATCCAKWNtEDKVsHVstGGGAsLELLEGKILPGVEAL |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S75 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | tGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | T166 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GMGTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| P07437 | T72 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | NEAtGGKyVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| P07864 | S167 | Sugiyama | LDHC LDH3 LDHX | VWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVHPTSCHG |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S505 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | KENQKHIyyItGETKDQVANsAFVERLRKHGLEVIyMIEPI |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T645 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKDLVIL |
| P08195 | S292 | Sugiyama | SLC3A2 MDU1 | VAQtDLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNY |
| P08195 | S296 | Sugiyama | SLC3A2 MDU1 | DLLQIDPNFGsKEDFDsLLQsAKKKSIRVILDLTPNYRGEN |
| P08195 | S410 | Sugiyama | SLC3A2 MDU1 | SLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLNATGNRW |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08195 | T599 | Sugiyama | SLC3A2 MDU1 | QASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEPH |
| P08195 | Y404 | Sugiyama | SLC3A2 MDU1 | DLQQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLN |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | S497 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEtQKsIyyItGEsKEQVANsAFVERVRKRGFEVVyMtEPI |
| P08238 | S532 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | yMtEPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| P08238 | S535 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EPIDEyCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P09104 | S37 | Sugiyama | ENO2 | NPtVEVDLyTAKGLFRAAVPsGAstGIyEALELRDGDKQRY |
| P09234 | T11 | Sugiyama | SNRPC | __________MPKFyCDyCDtyLtHDsPsVRKTHCSGRKHK |
| P09382 | S63 | Sugiyama | LGALS1 | CLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVFPFQPG |
| P09382 | T58 | Sugiyama | LGALS1 | DsNNLCLHFNPRFNAHGDANtIVCNsKDGGAWGTEQREAVF |
| P09429 | S35 | Sugiyama | HMGB1 HMG1 | syAFFVQtCREEHKKKHPDAsVNFsEFsKKCsERWKtMsAK |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0DPH7 | T73 | Sugiyama | TUBA3C TUBA2 | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| P0DPH7 | T80 | Sugiyama | TUBA3C TUBA2 | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAA |
| P0DPH7 | T82 | Sugiyama | TUBA3C TUBA2 | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANN |
| P0DPH7 | Y83 | Sugiyama | TUBA3C TUBA2 | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLItGKEDAANNy |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | T92 | Sugiyama | H1-4 H1F4 HIST1H1E | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P10412 | T96 | Sugiyama | H1-4 H1F4 HIST1H1E | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P10809 | S453 | Sugiyama | HSPD1 HSP60 | EEGIVLGGGCALLRCIPALDsLtPANEDQKIGIEIIKRTLK |
| P10809 | S67 | Sugiyama | HSPD1 HSP60 | LADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLK |
| P10809 | T231 | Sugiyama | HSPD1 HSP60 | LEIIEGMKFDRGyIsPyFINtsKGQKCEFQDAyVLLsEKKI |
| P10809 | T61 | Sugiyama | HSPD1 HSP60 | LQGVDLLADAVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVA |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11142 | T163 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VVtVPAyFNDsQRQAtKDAGtIAGLNVLRIINEPtAAAIAy |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P11142 | T47 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtNtV |
| P11142 | T64 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FtDtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQ |
| P11142 | T66 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DtERLIGDAAKNQVAMNPtNtVFDAKRLIGRRFDDAVVQsD |
| P11586 | S129 | Sugiyama | MTHFD1 MTHFC MTHFD | INTEEVINAIAPEKDVDGLtsINAGKLARGDLNDCFIPCtP |
| P11940 | T319 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KNLDDGIDDERLRKEFsPFGtItsAKVMMEGGRSKGFGFVC |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13073 | S72 | Sugiyama | COX4I1 COX4 | VKHLSASQKALKEKEKASWssLsMDEKVELYRIKFKEsFAE |
| P13639 | S38 | Sugiyama | EEF2 EF2 | NIRNMsVIAHVDHGKStLtDsLVCKAGIIAsARAGEtRFtD |
| P13639 | S578 | Sugiyama | EEF2 EF2 | LKDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNK |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13639 | T5 | Sugiyama | EEF2 EF2 | ________________MVNFtVDQIRAIMDKKANIRNMsVI |
| P13639 | T735 | Sugiyama | EEF2 EF2 | HRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCPEQV |
| P13639 | Y579 | Sugiyama | EEF2 EF2 | KDLEEDHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKH |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13674 | T140 | Sugiyama | P4HA1 P4HA | YFPNDEDQVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKS |
| P13674 | T147 | Sugiyama | P4HA1 P4HA | QVGAAKALLRLQDtyNLDTDtIsKGNLPGVKHKSFLTAEDC |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | S37 | Sugiyama | ENO3 | NPtVEVDLHtAKGRFRAAVPsGAstGIyEALELRDGDKGRY |
| P14314 | T115 | Sugiyama | PRKCSH G19P1 | GVCDCCDGtDEyNsGVICENtCKEKGRKEREsLQQMAEVtR |
| P14314 | T469 | Sugiyama | PRKCSH G19P1 | WGsWIGPDHDKFSAMKyEQGtGCWQGPNRstTVRLLCGKEt |
| P14618 | S202 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | SLQVKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVs |
| P14618 | S205 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | VKQKGADFLVtEVENGGsLGsKKGVNLPGAAVDLPAVsEKD |
| P14618 | T50 | Sugiyama | PKM OIP3 PK2 PK3 PKM2 | MCRLDIDsPPItARNtGIICtIGPAsRsVEtLKEMIKsGMN |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | T675 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | sGNMERIMKAQAYQtGKDIstNyyAsQKKTFEINPRHPLIR |
| P15311 | S535 | Sugiyama | EZR VIL2 | EKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHN |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | T533 | Sugiyama | EZR VIL2 | NEEKRITEAEKNERVQRQLLtLssELsQARDENKRTHNDII |
| P15531 | S122 | Sugiyama | NME1 NDPKA NM23 | GtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELVDy |
| P16401 | T95 | Sugiyama | H1-5 H1F5 HIST1H1B | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16401 | T99 | Sugiyama | H1-5 H1F5 HIST1H1B | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | T93 | Sugiyama | H1-3 H1F3 HIST1H1D | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16402 | T97 | Sugiyama | H1-3 H1F3 HIST1H1D | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAASGEG |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | T92 | Sugiyama | H1-2 H1F2 HIST1H1C | DVEKNNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAA |
| P16403 | T96 | Sugiyama | H1-2 H1F2 HIST1H1C | NNSRIKLGLKsLVsKGtLVQtKGtGAsGsFKLNKKAAsGEA |
| P17066 | T228 | Sugiyama | HSPA6 HSP70B' | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P18615 | S135 | Sugiyama | NELFE RD RDBP | sADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEAEG |
| P18621 | S111 | Sugiyama | RPL17 | LLHMLKNAESNAELKGLDVDsLVIEHIQVNKAPKMRRRTYR |
| P18669 | S155 | Sugiyama | PGAM1 PGAMA CDABP0006 | NIsKDRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQI |
| P18669 | T159 | Sugiyama | PGAM1 PGAMA CDABP0006 | DRRyADLtEDQLPsCEsLKDtIARALPFWNEEIVPQIKEGK |
| P19105 | T159 | Sugiyama | MYL12A MLCB MRLC3 RLC | DELyREAPIDKKGNFNyIEFtRILKHGAKDKDD________ |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P20290 | S126 | Sugiyama | BTF3 NACB OK/SW-cl.8 | VNMFTNQGTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEM |
| P20290 | T133 | Sugiyama | BTF3 NACB OK/SW-cl.8 | GTVIHFNNPKVQAsLAANtFtItGHAEtKQLTEMLPsILNQ |
| P20618 | S151 | Sugiyama | PSMB1 PSC5 | PYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASA |
| P20618 | S157 | Sugiyama | PSMB1 PSC5 | IIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLL |
| P20618 | Y158 | Sugiyama | PSMB1 PSC5 | IGGLDEEGKGAVysFDPVGsyQRDsFKAGGSASAMLQPLLD |
| P20674 | T105 | Sugiyama | COX5A | EPKIIDAALRACRRLNDFAstVRILEVVKDKAGPHKEIYPY |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22392 | S122 | Sugiyama | NME2 NM23B | GtIRGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDy |
| P22392 | S125 | Sugiyama | NME2 NM23B | RGDFCIQVGRNIIHGsDsVKsAEKEISLWFKPEELVDyKSC |
| P22626 | T140 | Sugiyama | HNRNPA2B1 HNRPA2B1 | KEDTEEHHLRDyFEEYGKIDtIEIItDRQsGKKRGFGFVtF |
| P23246 | S283 | Sugiyama | SFPQ PSF | GPGGRsEEKIsDsEGFKANLsLLRRPGEKTyTQRCRLFVGN |
| P23381 | S358 | Sugiyama | WARS1 IFI53 WARS WRS | TFFPALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFs |
| P23381 | T362 | Sugiyama | WARS1 IFI53 WARS WRS | ALQGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRD |
| P23381 | T364 | Sugiyama | WARS1 IFI53 WARS WRS | QGAQTKMsAsDPNssIFLtDtAKQIKTKVNKHAFsGGRDtI |
| P23396 | S35 | Sugiyama | RPS3 OK/SW-cl.26 | GIFKAELNEFLtRELAEDGysGVEVRVtPTRTEIIILATRT |
| P23396 | T26 | Sugiyama | RPS3 OK/SW-cl.26 | sKKRKFVADGIFKAELNEFLtRELAEDGysGVEVRVtPTRT |
| P23528 | T63 | Sugiyama | CFL1 CFL | DKKNIILEEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyA |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P23588 | T205 | Sugiyama | EIF4B | GRDRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYR |
| P24752 | S218 | Sugiyama | ACAT1 ACAT MAT | ENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNEVIPV |
| P25705 | S198 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | GIIPRIsVREPMQTGIKAVDsLVPIGRGQRELIIGDRQTGK |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26373 | S109 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | KVARTIGIsVDPRRRNKstEsLQANVQRLKEYRSKLILFPR |
| P26373 | S181 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | YKKEKARVItEEEKNFKAFAsLRMARANARLFGIRAKRAKE |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26373 | T148 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PRKPSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARV |
| P26373 | T151 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PSAPKKGDssAEELKLAtQLtGPVMPVRNVYKKEKARVItE |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P29692 | S37 | Sugiyama | EEF1D EF1D | KYDDAERRFyEQMNGPVAGAsRQENGAsVILRDIARARENI |
| P29692 | S44 | Sugiyama | EEF1D EF1D | RFyEQMNGPVAGAsRQENGAsVILRDIARARENIQKsLAGs |
| P30040 | T43 | Sugiyama | ERP29 C12orf8 ERP28 | LLSAPHGGSGLHTKGALPLDtVtFyKVIPKSKFVLVKFDtQ |
| P30040 | T45 | Sugiyama | ERP29 C12orf8 ERP28 | SAPHGGSGLHTKGALPLDtVtFyKVIPKSKFVLVKFDtQyP |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | T135 | Sugiyama | RPL12 | QMRHRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDI |
| P30050 | T25 | Sugiyama | RPL12 | FDPNEIKVVYLRCtGGEVGAtsALAPKIGPLGLsPKKVGDD |
| P30086 | S139 | Sugiyama | PEBP1 PBP PEBP | RyVWLVyEQDRPLKCDEPILsNRsGDHRGKFKVAsFRKKyE |
| P30086 | T167 | Sugiyama | PEBP1 PBP PEBP | GKFKVAsFRKKyELRAPVAGtCyQAEWDDyVPKLyEQLsGK |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P31943 | S285 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | NyCFsGMsDHRyGDGGstFQsttGHCVHMRGLPYRAtENDI |
| P31948 | S16 | Sugiyama | STIP1 | _____MEQVNELKEKGNKALsVGNIDDALQCysEAIKLDPH |
| P31948 | S28 | Sugiyama | STIP1 | KEKGNKALsVGNIDDALQCysEAIKLDPHNHVLysNRsAAy |
| P31948 | T243 | Sugiyama | STIP1 | KQALKEKELGNDAYKKKDFDtALKHYDKAKELDPtNMtyIT |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34931 | T228 | Sugiyama | HSPA1L | DVSILTIDDGIFEVKAtAGDtHLGGEDFDNRLVsHFVEEFK |
| P34931 | T49 | Sugiyama | HSPA1L | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQNTV |
| P35269 | T41 | Sugiyama | GTF2F1 RAP74 | NTTKKyNIMAFNAADKVNFAtWNQARLERDLSNKKIyQEEE |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | S1916 | Sugiyama | MYH9 | LQRELEDAtEtADAMNREVssLKNKLRRGDLPFVVPRRMAR |
| P35579 | T1904 | Sugiyama | MYH9 | EEAQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRG |
| P35579 | T1906 | Sugiyama | MYH9 | AQRANAsRRKLQRELEDAtEtADAMNREVssLKNKLRRGDL |
| P35637 | S462 | Sugiyama | FUS TLS | NECNQCKAPKPDGPGGGPGGsHMGGNyGDDRRGGRGGYDRG |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P36578 | S87 | Sugiyama | RPL4 RPL1 | WGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAPTKT |
| P36578 | T84 | Sugiyama | RPL4 RPL1 | AEsWGtGRAVARIPRVRGGGtHRsGQGAFGNMCRGGRMFAP |
| P37108 | S25 | Sugiyama | SRP14 | EsEQFLtELTRLFQKCRTSGsVyItLKKYDGRTKPIPKKGt |
| P37108 | T45 | Sugiyama | SRP14 | sVyItLKKYDGRTKPIPKKGtVEGFEPADNKCLLRATDGKK |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | T116 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | DGERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKD |
| P38646 | T120 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | LVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIKNV |
| P38646 | T398 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | SDIGEVILVGGMTRMPKVQQtVQDLFGRAPsKAVNPDEAVA |
| P38646 | T86 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | CVAVMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAK |
| P38646 | T94 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | QAKVLENAEGARttPsVVAFtADGERLVGMPAKRQAVtNPN |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | S59 | Sugiyama | RPS19 | LAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIY |
| P39019 | T55 | Sugiyama | RPS19 | DtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGsM |
| P39019 | T60 | Sugiyama | RPS19 | AKHKELAPyDENWFytRAAstARHLYLRGGAGVGsMTKIYG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P39687 | T105 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | EKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCEV |
| P40429 | T153 | Sugiyama | RPL13A | RKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQ |
| P40429 | T155 | Sugiyama | RPL13A | FAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYRKKKQLM |
| P41567 | T46 | Sugiyama | EIF1 SUI1 | GTEDyIHIRIQQRNGRKtLttVQGIADDyDKKKLVKAFKKK |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43034 | S152 | Sugiyama | PAFAH1B1 LIS1 MDCR MDS PAFAHA | IKVWDyEtGDFERtLKGHtDsVQDIsFDHsGKLLASCSADM |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S1447 | Sugiyama | MKI67 | EDKSINAFRETAKQKLDPAAsVtGsKRHPKTKEKAQPLEDL |
| P46379 | T1080 | GPS6 | BAG6 BAT3 G3 | QLLLSEAVSRAAKAAGARPLtsPEsLsRDLEAPEVQESYRQ |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46776 | T72 | Sugiyama | RPL27A | yFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRVNAAK |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P47914 | S142 | Sugiyama | RPL29 | KAKAKAKAKDQTKAQAAAPAsVPAQAPKRtQAPtKAsE___ |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | T228 | Sugiyama | HSPA7 HSP70B | DVSVLSIDAGVFEVKAtAGDtHLGGEDFDNRLVNHFMEEFR |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51116 | T610 | Sugiyama | FXR2 FMR1L2 | RRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQsRQRPPLER |
| P51149 | T168 | Sugiyama | RAB7A RAB7 | NIPyFEtSAKEAINVEQAFQtIARNALKQETEVELyNEFPE |
| P51532 | S1382 | Sugiyama | SMARCA4 BAF190A BRG1 SNF2B SNF2L4 | EEEKMFGRGSRHRKEVDYsDsLTEKQWLKAIEEGtLEEIEE |
| P51858 | S83 | Sugiyama | HDGF HMG1L2 | LFPyEEsKEKFGKPNKRKGFsEGLWEIENNPtVKASGYQSs |
| P51858 | T94 | Sugiyama | HDGF HMG1L2 | GKPNKRKGFsEGLWEIENNPtVKASGYQSsQKKsCVEEPEP |
| P52948 | S683 | Sugiyama | NUP98 ADAR2 | IAKPIPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEG |
| P52948 | T687 | Sugiyama | NUP98 ADAR2 | IPQtPEsAGNKHsNsNsVDDtIVALNMRAALRNGLEGssEE |
| P53999 | S17 | Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P53999 | S19 | Sugiyama | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P54652 | T48 | Sugiyama | HSPA2 | EIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTNTI |
| P55010 | T227 | Sugiyama | EIF5 | ttEEAQRRRMDEISDHAKVLtLsDDLERtIEERVNILFDFV |
| P55010 | T235 | Sugiyama | EIF5 | RMDEISDHAKVLtLsDDLERtIEERVNILFDFVKKKKEEGV |
| P55854 | S27 | Sugiyama | SUMO3 SMT3A SMT3H1 | KEGVKTENDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P60174 | S195 | Sugiyama | TPI1 TPI | KtATPQQAQEVHEKLRGWLKsNVsDAVAQstRIIyGGsVtG |
| P60174 | S204 | Sugiyama | TPI1 TPI | EVHEKLRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQ |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60174 | S97 | Sugiyama | TPI1 TPI | GEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELIGQKVAHA |
| P60174 | T214 | Sugiyama | TPI1 TPI | KsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGG |
| P60174 | T217 | Sugiyama | TPI1 TPI | VsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLVGGAsL |
| P60174 | T38 | Sugiyama | TPI1 TPI | RKQsLGELIGtLNAAKVPADtEVVCAPPtAyIDFARQKLDP |
| P60174 | T46 | Sugiyama | TPI1 TPI | IGtLNAAKVPADtEVVCAPPtAyIDFARQKLDPKIAVAAQN |
| P60174 | T90 | Sugiyama | TPI1 TPI | VTNGAFtGEIsPGMIKDCGAtWVVLGHsERRHVFGEsDELI |
| P60660 | T103 | Sugiyama | MYL6 | QGtyEDyVEGLRVFDKEGNGtVMGAEIRHVLVtLGEKMTEE |
| P60660 | T85 | Sugiyama | MYL6 | LDFEHFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVM |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S323 | Sugiyama | ACTB | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | S60 | Sugiyama | ACTB | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P60709 | T201 | Sugiyama | ACTB | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P60709 | T203 | Sugiyama | ACTB | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P60709 | T249 | Sugiyama | ACTB | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P60709 | T324 | Sugiyama | ACTB | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61247 | S203 | Sugiyama | RPS3A FTE1 MFTL | EVVNKLIPDsIGKDIEKACQsIyPLHDVFVRKVKMLKKPKF |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P61254 | T93 | Sugiyama | RPL26 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| P61254 | T94 | Sugiyama | RPL26 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | T33 | Sugiyama | RPL27 | VLAGRYSGRKAVIVKNIDDGtsDRPysHALVAGIDRyPRKV |
| P61353 | T94 | Sugiyama | RPL27 | VyNyNHLMPtRysVDIPLDKtVVNKDVFRDPALKRKARREA |
| P61353 | Y85 | Sugiyama | RPL27 | RSKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPA |
| P61604 | S64 | Sugiyama | HSPE1 | AtVVAVGsGsKGKGGEIQPVsVKVGDKVLLPEyGGtKVVLD |
| P61604 | T45 | Sugiyama | HSPE1 | TVTKGGIMLPEKSQGKVLQAtVVAVGsGsKGKGGEIQPVsV |
| P61956 | S28 | Sugiyama | SUMO2 SMT3B SMT3H2 | EGVKtENNDHINLKVAGQDGsVVQFKIKRHTPLSKLMKAYC |
| P61978 | S417 | Sugiyama | HNRNPK HNRPK | DLAGsIIGKGGQRIKQIRHEsGAsIKIDEPLEGsEDRIITI |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | S77 | Sugiyama | HNRNPK HNRPK | VIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIETI |
| P61981 | T31 | Sugiyama | YWHAG | ARLAEQAERyDDMAAAMKNVtELNEPLsNEERNLLsVAyKN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62258 | S148 | Sugiyama | YWHAE | YHRyLAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHP |
| P62263 | S139 | Sugiyama | RPS14 PRO2640 | LARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL________ |
| P62263 | S70 | Sugiyama | RPS14 PRO2640 | KETICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGI |
| P62263 | T140 | Sugiyama | RPS14 PRO2640 | ARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL_________ |
| P62263 | Y72 | Sugiyama | RPS14 PRO2640 | TICRVTGGMKVKADRDEssPyAAMLAAQDVAQRCKELGITA |
| P62266 | S45 | Sugiyama | RPS23 | KQYKKAHLGtALKANPFGGAsHAKGIVLEKVGVEAKQPNSA |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P62269 | T69 | Sugiyama | RPS18 D6S218E | DIDLTKRAGELtEDEVERVItIMQNPRQYKIPDWFLNRQKD |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | T15 | Sugiyama | RPS11 | ______MADIQTERAyQKQPtIFQNKKRVLLGEtGKEKLPR |
| P62280 | T54 | Sugiyama | RPS11 | PRYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILs |
| P62316 | T40 | Sugiyama | SNRPD2 SNRPD1 | EEEEFNtGPLsVLtQsVKNNtQVLINCRNNKKLLGRVKAFD |
| P62424 | T93 | Sugiyama | RPL7A SURF-3 SURF3 | RLKVPPAINQFtQALDRQTAtQLLKLAHKYRPEtKQEKKQR |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S325 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | S62 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P62736 | T251 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P62736 | T326 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62750 | T126 | Sugiyama | RPL23A | KHQIKQAVKKLyDIDVAKVNtLIRPDGEKKAYVRLAPDyDA |
| P62826 | T66 | Sugiyama | RAN ARA24 OK/SW-cl.81 | EVHPLVFHTNRGPIKFNVWDtAGQEKFGGLRDGYYIQAQCA |
| P62857 | S41 | Sugiyama | RPS28 | tGsQGQCtQVRVEFMDDtsRsIIRNVKGPVREGDVLtLLEs |
| P62857 | S61 | Sugiyama | RPS28 | sIIRNVKGPVREGDVLtLLEsEREARRLR____________ |
| P62857 | T57 | Sugiyama | RPS28 | DtsRsIIRNVKGPVREGDVLtLLEsEREARRLR________ |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62899 | T22 | Sugiyama | RPL31 | APAKKGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRA |
| P62899 | T26 | Sugiyama | RPL31 | KGGEKKKGRsAINEVVtREytINIHKRIHGVGFKKRAPRAL |
| P62917 | S138 | Sugiyama | RPL8 | EKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVI |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T135 | Sugiyama | RPL8 | CLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSK |
| P62917 | T143 | Sugiyama | RPL8 | RGKLARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANR |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62942 | T15 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______MGVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGK |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62942 | T28 | Sugiyama | FKBP1A FKBP1 FKBP12 | IsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRDRNKPFK |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S134 | Sugiyama | RPS27A UBA80 UBCEP1 | IsRLRRECPsDECGAGVFMAsHFDRHyCGKCCLtyCFNKPE |
| P62979 | T147 | Sugiyama | RPS27A UBA80 UBCEP1 | GAGVFMAsHFDRHyCGKCCLtyCFNKPEDK___________ |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S323 | Sugiyama | ACTG1 ACTG | ttMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGG |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | S60 | Sugiyama | ACTG1 ACTG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEHGIVTNWD |
| P63261 | T201 | Sugiyama | ACTG1 ACTG | AGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVAL |
| P63261 | T203 | Sugiyama | ACTG1 ACTG | RDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyVALDF |
| P63261 | T249 | Sugiyama | ACTG1 ACTG | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPsFLGM |
| P63261 | T324 | Sugiyama | ACTG1 ACTG | tMyPGIADRMQKEItALAPstMKIKIIAPPERKYsVWIGGs |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S324 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | S61 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P63267 | T250 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P63267 | T325 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S136 | Sugiyama | YBX1 NSEP1 YB1 | GEKGAEAANVtGPGGVPVQGsKYAADRNHYRRYPRRRGPPR |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P67809 | T89 | Sugiyama | YBX1 NSEP1 YB1 | RNGyGFINRNDtKEDVFVHQtAIKKNNPRKyLRsVGDGEtV |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | S325 | Sugiyama | ACTC1 ACTC | tTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | S62 | Sugiyama | ACTC1 ACTC | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68032 | T251 | Sugiyama | ACTC1 ACTC | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68032 | T326 | Sugiyama | ACTC1 ACTC | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S325 | Sugiyama | ACTA1 ACTA | TTMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGG |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | S62 | Sugiyama | ACTA1 ACTA | HQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEHGIItNWD |
| P68133 | T251 | Sugiyama | ACTA1 ACTA | tAAssssLEKsyELPDGQVItIGNERFRCPETLFQPSFIGM |
| P68133 | T326 | Sugiyama | ACTA1 ACTA | TMYPGIADRMQKEItALAPstMKIKIIAPPERKYSVWIGGS |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T82 | Sugiyama | TUBA1B | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| P68431 | S29 | EPSD | H3C1 H3FA HIST1H3A; H3C2 H3FL HIST1H3B; H3C3 H3FC HIST1H3C; H3C4 H3FB HIST1H3D; H3C6 H3FD HIST1H3E; H3C7 H3FI HIST1H3F; H3C8 H3FH HIST1H3G; H3C10 H3FK HIST1H3H; H3C11 H3FF HIST1H3I; H3C12 H3FJ HIST1H3J | RKstGGKAPRKQLATKAARKsAPATGGVKKPHRyRPGtVAL |
| P78371 | S60 | Sugiyama | CCT2 99D8.1 CCTB | KSTLGPKGMDKILLsSGRDAsLMVtNDGAtILKNIGVDNPA |
| P78371 | T69 | Sugiyama | CCT2 99D8.1 CCTB | DKILLsSGRDAsLMVtNDGAtILKNIGVDNPAAKVLVDMSR |
| P80723 | T222 | Sugiyama | BASP1 NAP22 | PAAsAEEPKPVEAPAANsDQtVtVKE_______________ |
| P80723 | T224 | Sugiyama | BASP1 NAP22 | AsAEEPKPVEAPAANsDQtVtVKE_________________ |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P83881 | S32 | Sugiyama | RPL36A RPL44 GIG15 MIG6 | CKKCGKHQPHKVTQYKKGKDsLyAQGKRRYDRKQsGYGGQT |
| P84098 | S122 | Sugiyama | RPL19 | LRRLLRRYRESKKIDRHMyHsLyLKVKGNVFKNKRILMEHI |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| P99999 | S48 | Sugiyama | CYCS CYC | KTGPNLHGLFGRKtGQAPGysytAANKNKGIIWGEDTLMEY |
| Q00839 | T530 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | KTTWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtG |
| Q00839 | T532 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | TWVTKHAAENPGKyNILGtNtIMDKMMVAGFKKQMADtGKL |
| Q01105 | S168 | Sugiyama | SET | ENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQN |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q02539 | T95 | Sugiyama | H1-1 H1F1 HIST1H1A | DVEKNNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKAS |
| Q02539 | T99 | Sugiyama | H1-1 H1F1 HIST1H1A | NNSRIKLGIKsLVsKGtLVQtKGtGAsGsFKLNKKASSVET |
| Q02543 | T101 | Sugiyama | RPL18A | WLRYDsRSGtHNMYREyRDLttAGAVtQCyRDMGARHRARA |
| Q02543 | T107 | Sugiyama | RPL18A | RSGtHNMYREyRDLttAGAVtQCyRDMGARHRARAHsIQIM |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q06830 | S152 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | IIDDKGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEV |
| Q06830 | T156 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | KGILRQItVNDLPVGRsVDEtLRLVQAFQFtDKHGEVCPAG |
| Q07955 | S182 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | FVRKEDMTYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsy |
| Q07955 | T187 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | DMTYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRs |
| Q12904 | T280 | Sugiyama | AIMP1 EMAP2 SCYE1 | PDKELNPKKKIWEQIQPDLHtNDECVAtyKGVPFEVKGKGV |
| Q12904 | T287 | Sugiyama | AIMP1 EMAP2 SCYE1 | KKKIWEQIQPDLHtNDECVAtyKGVPFEVKGKGVCRAQTMS |
| Q12906 | S317 | Sugiyama | ILF3 DRBF MPHOSPH4 NF90 | KEAtDAIGHLDRQQREDItQsAQHALRLAAFGQLHKVLGMD |
| Q13263 | S784 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | DVGRMFKQFNKLTEDKADVQsIIGLQRFFETRMNEAFGDTK |
| Q13283 | T241 | Sugiyama | G3BP1 G3BP | ETAPEDAQKsssPAPADIAQtVQEDLRtFsWAsVtsKNLPP |
| Q13435 | T315 | Sugiyama | SF3B2 SAP145 | EMETDARssLGQsAsEtEEDtVsVsKKEKNRKRRNRKKKKK |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S75 | Sugiyama | TUBB3 TUBB4 | SSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIFGQS |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13509 | T166 | Sugiyama | TUBB3 TUBB4 | GMGTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| Q13509 | T72 | Sugiyama | TUBB3 TUBB4 | NEASSHKYVPRAILVDLEPGtMDsVRSGAFGHLFRPDNFIF |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q13885 | S75 | Sugiyama | TUBB2A TUBB2 | AGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q13885 | T72 | Sugiyama | TUBB2A TUBB2 | NEAAGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14152 | S988 | Sugiyama | EIF3A EIF3S10 KIAA0139 | PRRGPEEDRFsRRGADDDRPsWRNTDDDRPPRRIADEDRGN |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14157 | T23 | Sugiyama | UBAP2L KIAA0144 NICE4 | TSVGTNRARGNWEQPQNQNQtQHKQRPQATAEQIRLAQMIS |
| Q14157 | T246 | Sugiyama | UBAP2L KIAA0144 NICE4 | GHFEPDDGTSAWRtAtEEWGtEDWNEDLsEtKIFtAsNVss |
| Q14192 | T234 | Sugiyama | FHL2 DRAL SLIM3 | CDLyAKKCAGCTNPISGLGGtKyIsFEERQWHNDCFNCKKC |
| Q14247 | S113 | Sugiyama | CTTN EMS1 | DRMDKsAVGHEyQSKLsKHCsQVDsVRGFGGKFGVQMDRVD |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14677 | S166 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | REERKKAKKNKDKyVGVssDsVGGFRysERYDPEPKSKWDE |
| Q14677 | T271 | Sugiyama | CLINT1 ENTH EPN4 EPNR KIAA0171 | KDEEETVTTKHIHItQATEttttRHKRTANPsKtIDLGAAA |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14978 | S637 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | GEKRAssPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGER |
| Q14978 | S643 | Sugiyama | NOLC1 KIAA0035 NS5ATP13 | sPFRRVREEEIEVDsRVADNsFDAKRGAAGDWGERANQVLK |
| Q14980 | S1183 | Sugiyama | NUMA1 NMP22 NUMA | ALEtLQGQLEEKAQELGHsQsALAsAQRELAAFRTKVQDHS |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15056 | S110 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | DEVDsLKEALtyDGALLGDRsLRVDIAEGRKQDKGGFGFRK |
| Q15056 | T100 | Sugiyama | EIF4H KIAA0038 WBSCR1 WSCR1 | KFKGFCyVEFDEVDsLKEALtyDGALLGDRsLRVDIAEGRK |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15293 | S159 | Sugiyama | RCN1 RCN | EyKQAtyGyyLGNPAEFHDssDHHtFKKMLPRDERRFKAAD |
| Q15293 | S69 | Sugiyama | RCN1 RCN | PPEDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVD |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15293 | T144 | Sugiyama | RCN1 RCN | WKDYDRDKDDKISWEEyKQAtyGyyLGNPAEFHDssDHHtF |
| Q15293 | T211 | Sugiyama | RCN1 RCN | FTAFLHPEEFEHMKEIVVLEtLEDIDKNGDGFVDQDEyIAD |
| Q15293 | T71 | Sugiyama | RCN1 RCN | EDNQsFQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRI |
| Q15427 | T14 | Sugiyama | SF3B4 SAP49 | _______MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFL |
| Q16630 | T404 | Sugiyama | CPSF6 CFIM68 | yGRPPPYDRGDyGPPGREMDtARtPLsEAEFEEIMNRNRAI |
| Q16658 | S234 | Sugiyama | FSCN1 FAN1 HSN SNL | LEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELF |
| Q27J81 | S1201 | Sugiyama | INF2 C14orf151 C14orf173 | PEsALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKR |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q3ZCM7 | S75 | Sugiyama | TUBB8 | SGGRYVPRAVLVDLEPGtMDsVRSGPFGQVFRPDNFIFGQC |
| Q562R1 | T250 | Sugiyama | ACTBL2 | RAAAssSPERsyELPDGQVItIGNERFRCPEAIFQPSFLGI |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | S370 | Sugiyama | HSP90AB3P HSP90BC | KETQKSTYYITGESKEQVANsAFVERVRKQGFEVVYMTEPI |
| Q58FF7 | S405 | Sugiyama | HSP90AB3P HSP90BC | YMTEPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKK |
| Q58FF7 | S408 | Sugiyama | HSP90AB3P HSP90BC | EPIDEYCVQQLKEFDGKsLVsVtKEGLELPEDEEEKKKMEE |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q58FF8 | S305 | Sugiyama | HSP90AB2P HSP90BB | RVVYMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKR |
| Q58FF8 | S308 | Sugiyama | HSP90AB2P HSP90BB | YMTEPIDGYQLKEFDGKsLVsVtKEGLELPEDGEEKKRMEE |
| Q5QJE6 | S703 | Sugiyama | DNTTIP2 ERBP TDIF2 | GFPKyFQIGtIVDNPADFyHsRIPKKQRKRTIVEELLADSE |
| Q5QJE6 | T692 | Sugiyama | DNTTIP2 ERBP TDIF2 | PKRFYKKNDRDGFPKyFQIGtIVDNPADFyHsRIPKKQRKR |
| Q5T3I0 | T356 | Sugiyama | GPATCH4 GPATC4 | RKKRQQQEEEDLNLEDRGEEtVLGGGTREAESRACSDGRSR |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6EEV6 | S28 | Sugiyama | SUMO4 SMT3H4 | EEVKTENNNHINLKVAGQDGsVVQFKIKRQTPLSKLMKAYC |
| Q6PEY2 | T73 | Sugiyama | TUBA3E | FsEtGAGKHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLI |
| Q6PEY2 | T80 | Sugiyama | TUBA3E | KHVPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAA |
| Q6PEY2 | T82 | Sugiyama | TUBA3E | VPRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASN |
| Q6PEY2 | Y83 | Sugiyama | TUBA3E | PRAVFVDLEPtVVDEVRtGtyRQLFHPEQLITGKEDAASNY |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6S8J3 | T949 | Sugiyama | POTEE A26C1A POTE2 | tAAssssLEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S167 | Sugiyama | LDHAL6A LDHL2 | AWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIHSESCHG |
| Q71RC2 | S392 | Sugiyama | LARP4 PP13296 | KNRVKPQFRssGGsEHstEGsVsLGDGQLNRYSSRNFPAER |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T82 | Sugiyama | TUBA1A TUBA3 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7RTV0 | S53 | Sugiyama | PHF5A | CDSyVRPCTLVRICDECNyGsyQGRCVICGGPGVSDAyyCK |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z4S6 | S708 | Sugiyama | KIF21A KIAA1708 KIF2 | KIRDTQLERDQVLQNLGsVEsysEEKAKKVRSEYEKKLQAM |
| Q7Z4V5 | S399 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKPQSS |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86UE4 | S306 | Sugiyama | MTDH AEG1 LYRIC | WNEKSVKLssQIsAGEEKWNsVsPAsAGKRKtEPSAWsQDt |
| Q86V81 | S8 | Sugiyama | ALYREF ALY BEF THOC4 | _____________MADKMDMsLDDIIKLNRSQRGGRGGGRG |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8WXX5 | S215 | Sugiyama | DNAJC9 | EEAKEAEMSRKELGLDEGVDsLKAAIQSRQKDRQKEMDNFL |
| Q92890 | S299 | Sugiyama | UFD1 UFD1L | KKVEEDEAGGRFVAFsGEGQsLRKKGRKP____________ |
| Q96CT7 | S141 | Sugiyama | CCDC124 | KsHLEVPLEENVNRRVLEEGsVEARTIEDAIAVLsVAEEAA |
| Q96IZ0 | T261 | Sugiyama | PAWR PAR4 | YsRTDRSGFPRYNRDANVsGtLVSSstLEKKIEDLEKEVVR |
| Q99543 | S275 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | RAQRKKEEMNRIRtLVDNAysCDPRIKKFKEEEKAKKEAEK |
| Q99613 | S865 | Sugiyama | EIF3C EIF3S8 | HRTEPTAQQNLALQLAEKLGsLVENNERVFDHKQGtyGGyF |
| Q99733 | T58 | Sugiyama | NAP1L4 NAP2 | LAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQVRCA |
| Q99733 | Y55 | Sugiyama | NAP1L4 NAP2 | PRVLAALQERLDNVPHtPssyIEtLPKAVKRRINALKQLQV |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T82 | Sugiyama | TUBA1C TUBA6 | VPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAANN |
| Q9BRA2 | S41 | Sugiyama | TXNDC17 TXNL5 | QHNGKTIFAyFTGSKDAGGKsWCPDCVQAEPVVREGLKHIS |
| Q9BRS2 | S130 | Sugiyama | RIOK1 RIO1 | DKVLRKFENKINLDKLNVtDsVINKVTEKSRQKEADMYRIK |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVA1 | S75 | Sugiyama | TUBB2B | tGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVFGQs |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVA1 | T72 | Sugiyama | TUBB2B | NEAtGNKYVPRAILVDLEPGtMDsVRsGPFGQIFRPDNFVF |
| Q9BY44 | S526 | Sugiyama | EIF2A CDA02 MSTP004 MSTP089 | sPDLAPtPAPQstPRNtVsQsIsGDPEIDKKIKNLKKKLKA |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9BYX7 | T249 | Sugiyama | POTEKP ACTBL3 FKSG30 | MAASSSSVEKsyELPDGQVItIGNERFRCPEALFQPCFLGM |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9H0C2 | S286 | Sugiyama | SLC25A31 AAC4 ANT4 SFEC | DCFVKIYQHEGISSFFRGAFsNVLRGTGGALVLVLYDKIKE |
| Q9H444 | S87 | Sugiyama | CHMP4B C20orf178 SHAX1 | QALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEVLK |
| Q9H444 | T103 | Sugiyama | CHMP4B C20orf178 SHAX1 | DGtLstIEFQREALENANtNtEVLKNMGYAAKAMKAAHDNM |
| Q9H444 | T85 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALQALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEV |
| Q9H444 | T88 | Sugiyama | CHMP4B C20orf178 SHAX1 | ALKRKKRYEKQLAQIDGtLstIEFQREALENANtNtEVLKN |
| Q9H788 | S124 | Sugiyama | SH2D4A PPP1R38 SH2A | LKAEQEAEEPRKTHsEEFTNsLKTKsQyHDLQAPDNQQtKD |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NYF8 | S198 | Sugiyama | BCLAF1 BTF KIAA0164 | PLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsGDIWPGLsA |
| Q9NYF8 | T190 | Sugiyama | BCLAF1 BTF KIAA0164 | EGEPQEEsPLKsKsQEEPKDtFEHDPsEsIDEFNKssAtsG |
| Q9NYL2 | S165 | GPS6|SIGNOR|EPSD|PSP | MAP3K20 MLK7 MLTK ZAK HCCS4 | GVLKICDFGASRFHNHttHMsLVGTFPWMAPEVIQSLPVSE |
| Q9NYL2 | T161 | GPS6|SIGNOR|EPSD|PSP | MAP3K20 MLK7 MLTK ZAK HCCS4 | IAADGVLKICDFGASRFHNHttHMsLVGTFPWMAPEVIQSL |
| Q9NYL2 | T162 | SIGNOR|EPSD|PSP | MAP3K20 MLK7 MLTK ZAK HCCS4 | AADGVLKICDFGASRFHNHttHMsLVGTFPWMAPEVIQSLP |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UMX5 | T130 | Sugiyama | NENF CIR2 SPUF | LTHDTTGLTAKELEALDEVFtKVYKAKYPIVGYTARRILNE |
| Q9UNF1 | T92 | Sugiyama | MAGED2 BCG1 | tPEAREAPAtQAssttQLtDtQVLAAENKSLAADTKKQNAD |
| Q9UNX3 | T93 | Sugiyama | RPL26L1 RPL26P1 | VYRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDK |
| Q9UNX3 | T94 | Sugiyama | RPL26L1 RPL26P1 | YRKKyVIyIERVQREKANGttVHVGIHPSKVVITRLKLDKD |
| Q9UNZ2 | S192 | Sugiyama | NSFL1C UBXN2C | KRQHssQDVHVVLKLWKsGFsLDNGELRSyQDPsNAQFLEs |
| Q9UQ35 | S864 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | VKsGtPPRQGsItsPQANEQsVtPQRRsCFEssPDPELKsR |
| Q9UQ35 | T1655 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGsRSs |
| Q9UQ80 | T200 | Sugiyama | PA2G4 EBP1 | TPIEGMLSHQLKQHVIDGEKtIIQNPTDQQKKDHEKAEFEV |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y2B0 | S115 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | QIDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKF |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2B0 | T132 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | NGEssELDLQGIRIDsDISGtLKFACEsIVEEyEDELIEFF |
| Q9Y2T7 | T124 | Sugiyama | YBX2 CSDA3 MSY2 | RNGyGFINRNDtKEDVFVHQtAIKRNNPRKFLRsVGDGEtV |
| Q9Y2T7 | T143 | Sugiyama | YBX2 CSDA3 MSY2 | QtAIKRNNPRKFLRsVGDGEtVEFDVVEGEKGAEATNVTGP |
| Q9Y2X3 | S434 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | AKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEI |
| Q9Y2X3 | T427 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | SGTGKALAKTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQ |
| Q9Y2X3 | T435 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | KTEKYEHKSEVKtyDPSGDstLPtCsKKRKIEQVDKEDEIT |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y450 | S67 | Sugiyama | HBS1L HBS1 KIAA1038 | KPsVEPVEEyDyEDLKEssNsVsNHQLSGFDQARLYsCLDH |
| Q9Y5L4 | S57 | Sugiyama | TIMM13 TIM13B TIMM13A TIMM13B | ELLQRMTDKCFRKCIGKPGGsLDNSEQKCIAMCMDRyMDAW |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Axon guidance | R-HSA-422475 | 9.969803e-14 | 13.001 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.739386e-12 | 11.760 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.165046e-12 | 11.665 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.640333e-12 | 11.117 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.993505e-11 | 10.700 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.265710e-11 | 10.645 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.918388e-11 | 10.535 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.293988e-11 | 10.201 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.482767e-10 | 9.829 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.571495e-10 | 9.804 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.915567e-10 | 9.718 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.580997e-10 | 9.588 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.910079e-10 | 9.536 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.398065e-10 | 9.469 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 5.773103e-10 | 9.239 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.781273e-10 | 9.109 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.800396e-10 | 9.055 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.000451e-09 | 9.000 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.710788e-09 | 8.767 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.907635e-09 | 8.720 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.459033e-09 | 8.609 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.401830e-09 | 8.619 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.532730e-09 | 8.596 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.769096e-09 | 8.322 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.858447e-09 | 8.164 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.016910e-09 | 8.096 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.820325e-09 | 8.055 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.304548e-08 | 7.885 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.565150e-08 | 7.805 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.954739e-08 | 7.709 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.190469e-08 | 7.659 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.381359e-08 | 7.358 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.045637e-08 | 7.297 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.448164e-08 | 7.264 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.963320e-08 | 7.157 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 7.885015e-08 | 7.103 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 8.241488e-08 | 7.084 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.331100e-08 | 7.030 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.119820e-07 | 6.951 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.202428e-07 | 6.657 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 2.180731e-07 | 6.661 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.575252e-07 | 6.589 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.371893e-07 | 6.472 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.485039e-07 | 6.348 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 7.379595e-07 | 6.132 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 8.557408e-07 | 6.068 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.140829e-07 | 6.039 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.082503e-06 | 5.966 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.109605e-06 | 5.955 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.284207e-06 | 5.891 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.445078e-06 | 5.840 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.600135e-06 | 5.796 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.814614e-06 | 5.741 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.882513e-06 | 5.725 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.037602e-06 | 5.691 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.212515e-06 | 5.655 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 2.428328e-06 | 5.615 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.443929e-06 | 5.612 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.371858e-06 | 5.625 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.586794e-06 | 5.587 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.772874e-06 | 5.557 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.887001e-06 | 5.540 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.420388e-06 | 5.466 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 3.462095e-06 | 5.461 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.685289e-06 | 5.434 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.675866e-06 | 5.435 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.796131e-06 | 5.421 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.836574e-06 | 5.416 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.016980e-06 | 5.221 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 7.436551e-06 | 5.129 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 8.671813e-06 | 5.062 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 8.671813e-06 | 5.062 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 8.671813e-06 | 5.062 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 8.671813e-06 | 5.062 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.667648e-06 | 5.062 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 8.466458e-06 | 5.072 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 8.466458e-06 | 5.072 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 8.851477e-06 | 5.053 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.049750e-05 | 4.979 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.167148e-05 | 4.933 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.593431e-05 | 4.798 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.593431e-05 | 4.798 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.766974e-05 | 4.753 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.021753e-05 | 4.694 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.132001e-05 | 4.671 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 2.329692e-05 | 4.633 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.338746e-05 | 4.631 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.338746e-05 | 4.631 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.387269e-05 | 4.622 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 2.799408e-05 | 4.553 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.797265e-05 | 4.421 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.820133e-05 | 4.418 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.966258e-05 | 4.304 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.749187e-05 | 4.323 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.820653e-05 | 4.107 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.320467e-05 | 4.080 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.069900e-04 | 3.971 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.093899e-04 | 3.961 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 1.147847e-04 | 3.940 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.147847e-04 | 3.940 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.167226e-04 | 3.933 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.189573e-04 | 3.925 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.465455e-04 | 3.834 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.552537e-04 | 3.809 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.689498e-04 | 3.772 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.985616e-04 | 3.702 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.985616e-04 | 3.702 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.150259e-04 | 3.668 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 2.326061e-04 | 3.633 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.381073e-04 | 3.623 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.529036e-04 | 3.597 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.662593e-04 | 3.575 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.714217e-04 | 3.566 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.859070e-04 | 3.544 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.889331e-04 | 3.539 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.014271e-04 | 3.521 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.279980e-04 | 3.484 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.317258e-04 | 3.479 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.409937e-04 | 3.467 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.409937e-04 | 3.467 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.599101e-04 | 3.444 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.165676e-04 | 3.380 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.350726e-04 | 3.361 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.182988e-04 | 3.285 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.267777e-04 | 3.278 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.344125e-04 | 3.272 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.344125e-04 | 3.272 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.850890e-04 | 3.233 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 5.850890e-04 | 3.233 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 5.850890e-04 | 3.233 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 5.850890e-04 | 3.233 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.009334e-04 | 3.154 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.617335e-04 | 3.118 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 8.698243e-04 | 3.061 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.064103e-04 | 3.043 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 9.740513e-04 | 3.011 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.071125e-03 | 2.970 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.261665e-03 | 2.899 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.192646e-03 | 2.923 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.236136e-03 | 2.908 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.192646e-03 | 2.923 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.289935e-03 | 2.889 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 1.322777e-03 | 2.879 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.371733e-03 | 2.863 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.429460e-03 | 2.845 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.429460e-03 | 2.845 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.457341e-03 | 2.836 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.464297e-03 | 2.834 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.749063e-03 | 2.757 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.641034e-03 | 2.785 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.641034e-03 | 2.785 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 1.743492e-03 | 2.759 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.749063e-03 | 2.757 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.695823e-03 | 2.771 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 1.710018e-03 | 2.767 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.842533e-03 | 2.735 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.908921e-03 | 2.719 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.993453e-03 | 2.700 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.075052e-03 | 2.683 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 2.090835e-03 | 2.680 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.334466e-03 | 2.632 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.334466e-03 | 2.632 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.467071e-03 | 2.608 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.827716e-03 | 2.549 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 2.827716e-03 | 2.549 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.866242e-03 | 2.543 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.885132e-03 | 2.540 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 2.885132e-03 | 2.540 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 2.937933e-03 | 2.532 | 0 | 0 |
| Immune System | R-HSA-168256 | 3.304195e-03 | 2.481 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.339515e-03 | 2.476 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 3.395065e-03 | 2.469 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.395065e-03 | 2.469 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.447180e-03 | 2.463 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.623286e-03 | 2.441 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.623286e-03 | 2.441 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.749811e-03 | 2.426 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.914443e-03 | 2.407 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.993758e-03 | 2.399 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.153543e-03 | 2.382 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.245245e-03 | 2.372 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.404001e-03 | 2.356 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.429131e-03 | 2.354 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 4.781795e-03 | 2.320 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 4.894862e-03 | 2.310 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 5.607040e-03 | 2.251 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.120542e-03 | 2.291 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.252240e-03 | 2.280 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.607040e-03 | 2.251 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.607040e-03 | 2.251 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.389956e-03 | 2.268 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 5.280197e-03 | 2.277 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.363096e-03 | 2.271 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.994299e-03 | 2.302 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.849066e-03 | 2.233 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.288538e-03 | 2.201 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 6.327187e-03 | 2.199 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.536335e-03 | 2.185 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.023933e-03 | 2.153 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.452583e-03 | 2.128 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 7.460218e-03 | 2.127 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.676616e-03 | 2.115 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.822440e-03 | 2.107 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 7.822440e-03 | 2.107 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.950057e-03 | 2.100 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.965462e-03 | 2.099 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.436265e-03 | 2.074 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 8.500958e-03 | 2.071 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.722310e-03 | 2.059 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 9.276993e-03 | 2.033 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.682389e-03 | 2.014 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.138758e-02 | 1.944 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.138758e-02 | 1.944 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.062878e-02 | 1.974 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.062878e-02 | 1.974 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.120396e-02 | 1.951 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.105954e-02 | 1.956 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.101084e-02 | 1.958 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.991887e-03 | 2.000 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.077905e-02 | 1.967 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.138758e-02 | 1.944 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.072078e-02 | 1.970 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.141520e-02 | 1.943 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.194508e-02 | 1.923 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.231084e-02 | 1.910 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.291549e-02 | 1.889 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.311907e-02 | 1.882 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 1.311991e-02 | 1.882 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.328945e-02 | 1.876 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 1.332953e-02 | 1.875 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.433468e-02 | 1.844 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.437259e-02 | 1.842 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.497586e-02 | 1.825 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.497586e-02 | 1.825 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.514068e-02 | 1.820 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.534779e-02 | 1.814 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.558889e-02 | 1.807 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.574081e-02 | 1.803 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.583413e-02 | 1.800 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.583413e-02 | 1.800 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.924372e-02 | 1.716 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.924372e-02 | 1.716 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.924372e-02 | 1.716 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.924372e-02 | 1.716 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.924372e-02 | 1.716 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.924372e-02 | 1.716 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 1.639766e-02 | 1.785 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.722444e-02 | 1.764 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.686671e-02 | 1.773 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.887781e-02 | 1.724 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.753416e-02 | 1.756 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.722444e-02 | 1.764 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.796989e-02 | 1.745 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.887781e-02 | 1.724 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.887781e-02 | 1.724 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.619740e-02 | 1.791 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.796989e-02 | 1.745 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.835030e-02 | 1.736 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.995714e-02 | 1.700 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.046367e-02 | 1.689 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.046367e-02 | 1.689 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.100734e-02 | 1.678 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 2.100734e-02 | 1.678 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 2.100734e-02 | 1.678 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.100734e-02 | 1.678 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.100734e-02 | 1.678 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 2.150413e-02 | 1.667 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 2.166887e-02 | 1.664 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.273625e-02 | 1.643 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.273625e-02 | 1.643 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.483152e-02 | 1.605 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.500564e-02 | 1.602 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 2.517261e-02 | 1.599 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 2.517261e-02 | 1.599 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.598909e-02 | 1.585 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.625404e-02 | 1.581 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.625404e-02 | 1.581 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.739462e-02 | 1.562 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.739462e-02 | 1.562 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 2.905472e-02 | 1.537 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 2.905472e-02 | 1.537 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 3.213592e-02 | 1.493 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.213592e-02 | 1.493 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.007105e-02 | 1.522 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 3.178891e-02 | 1.498 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.981377e-02 | 1.526 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.985963e-02 | 1.525 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.128820e-02 | 1.505 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.213592e-02 | 1.493 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.451047e-02 | 1.462 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.451047e-02 | 1.462 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.350483e-02 | 1.475 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.213592e-02 | 1.493 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 3.382504e-02 | 1.471 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 3.213592e-02 | 1.493 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.451047e-02 | 1.462 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.451047e-02 | 1.462 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 3.240152e-02 | 1.489 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.089619e-02 | 1.510 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.058402e-02 | 1.515 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 3.062028e-02 | 1.514 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 3.350483e-02 | 1.475 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.887003e-02 | 1.540 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.777697e-02 | 1.556 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.777697e-02 | 1.556 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.453705e-02 | 1.462 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.618590e-02 | 1.441 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 3.626283e-02 | 1.441 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.652725e-02 | 1.437 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.663502e-02 | 1.436 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 3.663502e-02 | 1.436 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.697734e-02 | 1.432 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 3.717121e-02 | 1.430 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.770477e-02 | 1.424 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 3.909563e-02 | 1.408 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.926425e-02 | 1.406 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.931009e-02 | 1.405 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.988325e-02 | 1.399 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.994655e-02 | 1.399 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.994655e-02 | 1.399 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.042622e-02 | 1.393 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.043476e-02 | 1.393 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.043476e-02 | 1.393 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 4.043476e-02 | 1.393 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.043476e-02 | 1.393 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.043476e-02 | 1.393 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.178191e-02 | 1.379 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.178191e-02 | 1.379 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 4.337020e-02 | 1.363 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.577188e-02 | 1.339 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.605083e-02 | 1.337 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.751470e-02 | 1.323 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.772440e-02 | 1.321 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.772440e-02 | 1.321 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.809678e-02 | 1.318 | 0 | 0 |
| Disease | R-HSA-1643685 | 5.066991e-02 | 1.295 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 5.077131e-02 | 1.294 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 5.124106e-02 | 1.290 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 5.124106e-02 | 1.290 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.717219e-02 | 1.173 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.349851e-02 | 1.272 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 6.180671e-02 | 1.209 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 6.180671e-02 | 1.209 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 6.869559e-02 | 1.163 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.718145e-02 | 1.243 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.152704e-02 | 1.288 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.510754e-02 | 1.259 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.272308e-02 | 1.203 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.400816e-02 | 1.194 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 5.618166e-02 | 1.250 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.349851e-02 | 1.272 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 6.675942e-02 | 1.175 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.232800e-02 | 1.281 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.717219e-02 | 1.173 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.400816e-02 | 1.194 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 5.587320e-02 | 1.253 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.763625e-02 | 1.170 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 5.349851e-02 | 1.272 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.070364e-02 | 1.217 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.717219e-02 | 1.173 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.717219e-02 | 1.173 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.703495e-02 | 1.244 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.618166e-02 | 1.250 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 5.349851e-02 | 1.272 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.319766e-02 | 1.274 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.717219e-02 | 1.173 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.180671e-02 | 1.209 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 6.180671e-02 | 1.209 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.373136e-02 | 1.196 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.647320e-02 | 1.177 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.929488e-02 | 1.227 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.400816e-02 | 1.194 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.479412e-02 | 1.261 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.228451e-02 | 1.206 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.400816e-02 | 1.194 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 6.091723e-02 | 1.215 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.717219e-02 | 1.173 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.349851e-02 | 1.272 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.717219e-02 | 1.173 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.319766e-02 | 1.274 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.319766e-02 | 1.274 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 6.612343e-02 | 1.180 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.587320e-02 | 1.253 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 6.210907e-02 | 1.207 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.373136e-02 | 1.196 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.510754e-02 | 1.259 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.717219e-02 | 1.173 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.835787e-02 | 1.165 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.763625e-02 | 1.170 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.929525e-02 | 1.159 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.067473e-02 | 1.151 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 7.148899e-02 | 1.146 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.317410e-02 | 1.136 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.323510e-02 | 1.135 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 7.529071e-02 | 1.123 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.562680e-02 | 1.121 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.562680e-02 | 1.121 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.562680e-02 | 1.121 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 7.654134e-02 | 1.116 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 7.907886e-02 | 1.102 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.907886e-02 | 1.102 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 7.907886e-02 | 1.102 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 7.921447e-02 | 1.101 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.978553e-02 | 1.098 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.978553e-02 | 1.098 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.981496e-02 | 1.098 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.007857e-02 | 1.096 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.007857e-02 | 1.096 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.007857e-02 | 1.096 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.190131e-02 | 1.087 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 8.220097e-02 | 1.085 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 8.220097e-02 | 1.085 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 8.289559e-02 | 1.081 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.289559e-02 | 1.081 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.289559e-02 | 1.081 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.337270e-02 | 1.079 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.516474e-02 | 1.070 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.557468e-02 | 1.068 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.656565e-02 | 1.063 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.656565e-02 | 1.063 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.658359e-02 | 1.063 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.658359e-02 | 1.063 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.658359e-02 | 1.063 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.796356e-02 | 1.056 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 9.985942e-02 | 1.001 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 9.985942e-02 | 1.001 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 9.985942e-02 | 1.001 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 9.985942e-02 | 1.001 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.985942e-02 | 1.001 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 9.985942e-02 | 1.001 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 9.985942e-02 | 1.001 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 9.985942e-02 | 1.001 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 9.985942e-02 | 1.001 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 9.985942e-02 | 1.001 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 9.985942e-02 | 1.001 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 9.813955e-02 | 1.008 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 9.813955e-02 | 1.008 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 9.813955e-02 | 1.008 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.813955e-02 | 1.008 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.322275e-01 | 0.879 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 1.322275e-01 | 0.879 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.322275e-01 | 0.879 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 1.322275e-01 | 0.879 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.999241e-02 | 1.046 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 8.999241e-02 | 1.046 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.112399e-01 | 0.954 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.112399e-01 | 0.954 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.841249e-02 | 1.007 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.841249e-02 | 1.007 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 1.048386e-01 | 0.979 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.265389e-01 | 0.898 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.222197e-01 | 0.913 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.225161e-01 | 0.912 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.049298e-01 | 0.979 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.208855e-01 | 0.918 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.049385e-02 | 1.043 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.322275e-01 | 0.879 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.148555e-01 | 0.940 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.190893e-01 | 0.924 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.841249e-02 | 1.007 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.841249e-02 | 1.007 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.804880e-02 | 1.009 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.258509e-02 | 1.033 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.186215e-01 | 0.926 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.225161e-01 | 0.912 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.048386e-01 | 0.979 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.048386e-01 | 0.979 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 8.999241e-02 | 1.046 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.031115e-02 | 1.044 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 1.003890e-01 | 0.998 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.225161e-01 | 0.912 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.118539e-01 | 0.951 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.314520e-01 | 0.881 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 9.928013e-02 | 1.003 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.147968e-01 | 0.940 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.416875e-02 | 1.026 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.147968e-01 | 0.940 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 9.985942e-02 | 1.001 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.322275e-01 | 0.879 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 1.225161e-01 | 0.912 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.225161e-01 | 0.912 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 1.048386e-01 | 0.979 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 1.048386e-01 | 0.979 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.024519e-01 | 0.989 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.021358e-01 | 0.991 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.165226e-01 | 0.934 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.021358e-01 | 0.991 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.045277e-01 | 0.981 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.813955e-02 | 1.008 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 9.813955e-02 | 1.008 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.699099e-02 | 1.013 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.169620e-01 | 0.932 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.151704e-01 | 0.939 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.304155e-01 | 0.885 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.841249e-02 | 1.007 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.239877e-01 | 0.907 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.322275e-01 | 0.879 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 1.160837e-01 | 0.935 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 9.813955e-02 | 1.008 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.225161e-01 | 0.912 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.841249e-02 | 1.007 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.048386e-01 | 0.979 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.118539e-01 | 0.951 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 1.282970e-01 | 0.892 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 1.225161e-01 | 0.912 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 1.066416e-01 | 0.972 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.099220e-01 | 0.959 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 9.813955e-02 | 1.008 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.322275e-01 | 0.879 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.322275e-01 | 0.879 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 1.248320e-01 | 0.904 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.322275e-01 | 0.879 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.049385e-02 | 1.043 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.265389e-01 | 0.898 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.021358e-01 | 0.991 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.265389e-01 | 0.898 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.232023e-01 | 0.909 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.841249e-02 | 1.007 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.329801e-01 | 0.876 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.330813e-01 | 0.876 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 1.330813e-01 | 0.876 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.341880e-01 | 0.872 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.358105e-01 | 0.867 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.387047e-01 | 0.858 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.415512e-01 | 0.849 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.420560e-01 | 0.848 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.424390e-01 | 0.846 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 1.451802e-01 | 0.838 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.452595e-01 | 0.838 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.452595e-01 | 0.838 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 1.459892e-01 | 0.836 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 1.459892e-01 | 0.836 | 0 | 0 |
| MPS IIID - Sanfilippo syndrome D | R-HSA-2206305 | 1.459892e-01 | 0.836 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 1.459892e-01 | 0.836 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 1.459892e-01 | 0.836 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 1.459892e-01 | 0.836 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 1.459892e-01 | 0.836 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 1.459892e-01 | 0.836 | 0 | 0 |
| Defective SLC12A3 causes Gitelman syndrome (GS) | R-HSA-5619087 | 1.459892e-01 | 0.836 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 1.459892e-01 | 0.836 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 1.459892e-01 | 0.836 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 1.459892e-01 | 0.836 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 1.459892e-01 | 0.836 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 1.459892e-01 | 0.836 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.462207e-01 | 0.835 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.475654e-01 | 0.831 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 1.478755e-01 | 0.830 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.487072e-01 | 0.828 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.501447e-01 | 0.823 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.501447e-01 | 0.823 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.501447e-01 | 0.823 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.501447e-01 | 0.823 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.501447e-01 | 0.823 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.501447e-01 | 0.823 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.501447e-01 | 0.823 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.501447e-01 | 0.823 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.501447e-01 | 0.823 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.520477e-01 | 0.818 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.520477e-01 | 0.818 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.583514e-01 | 0.800 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 1.585991e-01 | 0.800 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.585991e-01 | 0.800 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.597408e-01 | 0.797 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.612636e-01 | 0.792 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.612636e-01 | 0.792 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 1.669291e-01 | 0.777 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.673580e-01 | 0.776 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 1.682201e-01 | 0.774 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 1.682201e-01 | 0.774 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.685056e-01 | 0.773 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.685056e-01 | 0.773 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.685056e-01 | 0.773 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 1.685056e-01 | 0.773 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.685056e-01 | 0.773 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.685056e-01 | 0.773 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.685056e-01 | 0.773 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 1.685056e-01 | 0.773 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.685056e-01 | 0.773 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.685056e-01 | 0.773 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 1.706660e-01 | 0.768 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 1.712788e-01 | 0.766 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.712788e-01 | 0.766 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 1.897575e-01 | 0.722 | 0 | 0 |
| Defective SLC12A1 causes Bartter syndrome 1 (BS1) | R-HSA-5619104 | 1.897575e-01 | 0.722 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.312852e-01 | 0.636 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.312852e-01 | 0.636 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 2.312852e-01 | 0.636 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 2.312852e-01 | 0.636 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 2.312852e-01 | 0.636 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.706869e-01 | 0.568 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 2.706869e-01 | 0.568 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 2.706869e-01 | 0.568 | 0 | 0 |
| Defective PNP disrupts phosphorolysis of (deoxy)guanosine and (deoxy)inosine | R-HSA-9735763 | 2.706869e-01 | 0.568 | 0 | 0 |
| Nucleotide catabolism defects | R-HSA-9735786 | 2.706869e-01 | 0.568 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 2.706869e-01 | 0.568 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 2.706869e-01 | 0.568 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 2.706869e-01 | 0.568 | 0 | 0 |
| IRS activation | R-HSA-74713 | 3.080713e-01 | 0.511 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 3.080713e-01 | 0.511 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.872181e-01 | 0.728 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 1.872181e-01 | 0.728 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.872181e-01 | 0.728 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.061979e-01 | 0.686 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.061979e-01 | 0.686 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 2.061979e-01 | 0.686 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.061979e-01 | 0.686 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.061979e-01 | 0.686 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.061979e-01 | 0.686 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.061979e-01 | 0.686 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.061979e-01 | 0.686 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.061979e-01 | 0.686 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 3.435414e-01 | 0.464 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 3.435414e-01 | 0.464 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 3.435414e-01 | 0.464 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 3.435414e-01 | 0.464 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.435414e-01 | 0.464 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 2.253687e-01 | 0.647 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.842351e-01 | 0.735 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.640125e-01 | 0.578 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.640125e-01 | 0.578 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.640125e-01 | 0.578 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 1.974391e-01 | 0.705 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.026711e-01 | 0.519 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.662047e-01 | 0.575 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 3.409567e-01 | 0.467 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 2.363228e-01 | 0.626 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.363228e-01 | 0.626 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.113058e-01 | 0.675 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 2.589383e-01 | 0.587 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 2.589383e-01 | 0.587 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 2.704020e-01 | 0.568 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 2.704020e-01 | 0.568 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.689856e-01 | 0.570 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 3.052584e-01 | 0.515 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 3.052584e-01 | 0.515 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.008708e-01 | 0.522 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.173165e-01 | 0.499 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 3.256396e-01 | 0.487 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.302288e-01 | 0.481 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.302288e-01 | 0.481 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.190486e-01 | 0.496 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.190486e-01 | 0.496 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 1.974391e-01 | 0.705 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.190486e-01 | 0.496 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.993339e-01 | 0.700 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.945091e-01 | 0.531 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.719651e-01 | 0.765 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.493469e-01 | 0.603 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 2.446611e-01 | 0.611 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 2.475740e-01 | 0.606 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.229869e-01 | 0.491 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 1.719651e-01 | 0.765 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.409567e-01 | 0.467 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 3.052584e-01 | 0.515 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 1.842351e-01 | 0.735 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.218817e-01 | 0.492 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.229869e-01 | 0.491 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.524866e-01 | 0.598 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.683399e-01 | 0.571 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 2.060107e-01 | 0.686 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 3.372381e-01 | 0.472 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 2.265521e-01 | 0.645 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 2.589383e-01 | 0.587 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.287563e-01 | 0.483 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.872181e-01 | 0.728 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.640125e-01 | 0.578 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.640125e-01 | 0.578 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.662047e-01 | 0.575 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.989878e-01 | 0.524 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.821447e-01 | 0.740 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.206401e-01 | 0.656 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 2.819520e-01 | 0.550 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.152062e-01 | 0.667 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 2.833662e-01 | 0.548 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.591219e-01 | 0.586 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 2.706869e-01 | 0.568 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 3.080713e-01 | 0.511 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 3.080713e-01 | 0.511 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 3.435414e-01 | 0.464 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.719651e-01 | 0.765 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 2.819520e-01 | 0.550 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.979661e-01 | 0.703 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.833662e-01 | 0.548 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 2.253687e-01 | 0.647 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.706869e-01 | 0.568 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.706869e-01 | 0.568 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 3.080713e-01 | 0.511 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 3.435414e-01 | 0.464 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.446611e-01 | 0.611 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.833662e-01 | 0.548 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 3.256396e-01 | 0.487 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.141104e-01 | 0.669 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.060107e-01 | 0.686 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.927245e-01 | 0.715 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.244351e-01 | 0.489 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.229869e-01 | 0.491 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 1.923595e-01 | 0.716 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 2.589383e-01 | 0.587 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 2.312852e-01 | 0.636 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.706869e-01 | 0.568 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 3.080713e-01 | 0.511 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.872181e-01 | 0.728 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.872181e-01 | 0.728 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.872181e-01 | 0.728 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.061979e-01 | 0.686 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.435414e-01 | 0.464 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 3.435414e-01 | 0.464 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 3.435414e-01 | 0.464 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.833662e-01 | 0.548 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.244770e-01 | 0.649 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 2.803242e-01 | 0.552 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.223896e-01 | 0.653 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.990246e-01 | 0.524 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.990246e-01 | 0.524 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.817118e-01 | 0.741 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.359581e-01 | 0.627 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.822465e-01 | 0.739 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.409567e-01 | 0.467 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.409567e-01 | 0.467 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 1.719651e-01 | 0.765 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.591219e-01 | 0.586 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.925956e-01 | 0.534 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.080713e-01 | 0.511 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.251983e-01 | 0.647 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.627388e-01 | 0.580 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 2.833662e-01 | 0.548 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.836468e-01 | 0.547 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 3.379747e-01 | 0.471 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.706869e-01 | 0.568 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 3.080713e-01 | 0.511 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 1.845695e-01 | 0.734 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.206401e-01 | 0.656 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.396693e-01 | 0.620 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 1.845695e-01 | 0.734 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.005453e-01 | 0.698 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.847855e-01 | 0.545 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.206401e-01 | 0.656 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.976852e-01 | 0.526 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.879318e-01 | 0.726 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.295609e-01 | 0.482 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 2.312852e-01 | 0.636 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 2.706869e-01 | 0.568 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 2.061979e-01 | 0.686 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 3.435414e-01 | 0.464 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.640125e-01 | 0.578 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 1.974391e-01 | 0.705 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.990246e-01 | 0.524 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.307726e-01 | 0.637 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.446611e-01 | 0.611 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.841251e-01 | 0.735 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 2.589383e-01 | 0.587 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.295609e-01 | 0.482 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.704020e-01 | 0.568 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.033852e-01 | 0.692 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.477941e-01 | 0.606 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 2.640125e-01 | 0.578 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 2.382563e-01 | 0.623 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.939683e-01 | 0.712 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.706869e-01 | 0.568 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.872181e-01 | 0.728 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 3.435414e-01 | 0.464 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 3.435414e-01 | 0.464 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 2.253687e-01 | 0.647 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 2.253687e-01 | 0.647 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.803242e-01 | 0.552 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 1.858594e-01 | 0.731 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.763661e-01 | 0.559 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.640125e-01 | 0.578 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.033852e-01 | 0.692 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.372381e-01 | 0.472 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.872181e-01 | 0.728 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.142145e-01 | 0.669 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 3.080713e-01 | 0.511 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.080713e-01 | 0.511 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 3.435414e-01 | 0.464 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 3.435414e-01 | 0.464 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 1.974391e-01 | 0.705 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 3.026711e-01 | 0.519 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 1.918713e-01 | 0.717 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.196229e-01 | 0.658 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.561594e-01 | 0.591 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.196229e-01 | 0.658 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.196229e-01 | 0.658 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.740925e-01 | 0.759 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 2.686827e-01 | 0.571 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.683399e-01 | 0.571 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 2.300975e-01 | 0.638 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 2.253687e-01 | 0.647 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.719651e-01 | 0.765 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.945091e-01 | 0.531 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 3.218817e-01 | 0.492 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 2.889454e-01 | 0.539 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 3.026711e-01 | 0.519 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 2.149657e-01 | 0.668 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.974391e-01 | 0.705 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.829232e-01 | 0.548 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 2.889454e-01 | 0.539 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 2.889454e-01 | 0.539 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 2.889454e-01 | 0.539 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 2.889454e-01 | 0.539 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 3.409567e-01 | 0.467 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 3.514715e-01 | 0.454 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 3.514715e-01 | 0.454 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.514715e-01 | 0.454 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.523497e-01 | 0.453 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 3.598598e-01 | 0.444 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 3.598598e-01 | 0.444 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 3.598598e-01 | 0.444 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.598598e-01 | 0.444 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.598598e-01 | 0.444 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.598598e-01 | 0.444 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.613613e-01 | 0.442 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.626003e-01 | 0.441 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 3.641537e-01 | 0.439 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.656688e-01 | 0.437 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.656688e-01 | 0.437 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 3.676816e-01 | 0.435 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.759481e-01 | 0.425 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.761456e-01 | 0.425 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 3.761456e-01 | 0.425 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.771954e-01 | 0.423 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.771954e-01 | 0.423 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 3.771954e-01 | 0.423 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 3.771954e-01 | 0.423 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 3.771954e-01 | 0.423 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 3.771954e-01 | 0.423 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 3.771954e-01 | 0.423 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.771954e-01 | 0.423 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 3.771954e-01 | 0.423 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 3.771954e-01 | 0.423 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.771954e-01 | 0.423 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.785585e-01 | 0.422 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.785585e-01 | 0.422 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 3.785585e-01 | 0.422 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 3.785585e-01 | 0.422 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 3.798128e-01 | 0.420 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.834924e-01 | 0.416 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.846184e-01 | 0.415 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 3.849008e-01 | 0.415 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 3.877226e-01 | 0.411 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.909613e-01 | 0.408 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.930959e-01 | 0.406 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.938873e-01 | 0.405 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.938873e-01 | 0.405 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.970242e-01 | 0.401 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.970242e-01 | 0.401 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.970242e-01 | 0.401 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.970242e-01 | 0.401 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.006349e-01 | 0.397 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 4.015502e-01 | 0.396 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.015743e-01 | 0.396 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.048836e-01 | 0.393 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.048836e-01 | 0.393 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.078771e-01 | 0.389 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 4.091259e-01 | 0.388 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 4.091259e-01 | 0.388 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 4.091259e-01 | 0.388 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 4.091259e-01 | 0.388 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 4.091259e-01 | 0.388 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.091259e-01 | 0.388 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 4.091259e-01 | 0.388 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 4.091259e-01 | 0.388 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 4.091259e-01 | 0.388 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 4.091259e-01 | 0.388 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 4.091259e-01 | 0.388 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.091259e-01 | 0.388 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 4.091259e-01 | 0.388 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 4.091259e-01 | 0.388 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 4.095581e-01 | 0.388 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 4.110603e-01 | 0.386 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.111722e-01 | 0.386 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.141317e-01 | 0.383 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.152315e-01 | 0.382 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 4.152315e-01 | 0.382 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.152315e-01 | 0.382 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.152315e-01 | 0.382 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.152315e-01 | 0.382 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 4.152315e-01 | 0.382 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.152315e-01 | 0.382 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.163721e-01 | 0.381 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 4.185180e-01 | 0.378 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.215068e-01 | 0.375 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.217679e-01 | 0.375 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.217679e-01 | 0.375 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.227970e-01 | 0.374 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 4.255091e-01 | 0.371 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.331585e-01 | 0.363 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 4.331585e-01 | 0.363 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.344277e-01 | 0.362 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.344277e-01 | 0.362 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.344277e-01 | 0.362 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 4.344277e-01 | 0.362 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.354189e-01 | 0.361 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.355466e-01 | 0.361 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.355466e-01 | 0.361 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.355466e-01 | 0.361 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 4.388689e-01 | 0.358 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 4.394213e-01 | 0.357 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.394213e-01 | 0.357 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 4.394213e-01 | 0.357 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.394213e-01 | 0.357 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.394213e-01 | 0.357 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.394213e-01 | 0.357 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 4.394213e-01 | 0.357 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.394213e-01 | 0.357 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 4.394213e-01 | 0.357 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 4.394213e-01 | 0.357 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 4.394213e-01 | 0.357 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.394213e-01 | 0.357 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.394213e-01 | 0.357 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 4.394213e-01 | 0.357 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 4.394213e-01 | 0.357 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.394213e-01 | 0.357 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 4.397017e-01 | 0.357 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.416702e-01 | 0.355 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 4.424128e-01 | 0.354 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.426418e-01 | 0.354 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.435956e-01 | 0.353 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.435956e-01 | 0.353 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.435956e-01 | 0.353 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.438442e-01 | 0.353 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.466503e-01 | 0.350 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 4.473986e-01 | 0.349 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.480274e-01 | 0.349 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.492007e-01 | 0.348 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.492007e-01 | 0.348 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.492007e-01 | 0.348 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.507860e-01 | 0.346 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 4.507860e-01 | 0.346 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 4.507860e-01 | 0.346 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.577860e-01 | 0.339 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 4.627189e-01 | 0.335 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.627189e-01 | 0.335 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.627189e-01 | 0.335 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.680978e-01 | 0.330 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 4.680978e-01 | 0.330 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 4.680978e-01 | 0.330 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.680978e-01 | 0.330 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.681650e-01 | 0.330 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.681650e-01 | 0.330 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.681650e-01 | 0.330 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.681650e-01 | 0.330 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.681650e-01 | 0.330 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.681650e-01 | 0.330 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 4.681650e-01 | 0.330 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 4.681650e-01 | 0.330 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.681650e-01 | 0.330 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.681650e-01 | 0.330 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.681650e-01 | 0.330 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.681650e-01 | 0.330 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.681650e-01 | 0.330 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.681650e-01 | 0.330 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 4.681650e-01 | 0.330 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.681650e-01 | 0.330 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 4.681650e-01 | 0.330 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.687992e-01 | 0.329 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 4.701524e-01 | 0.328 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 4.711268e-01 | 0.327 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.726172e-01 | 0.325 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.752919e-01 | 0.323 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 4.772966e-01 | 0.321 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 4.772966e-01 | 0.321 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.800894e-01 | 0.319 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 4.800894e-01 | 0.319 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.811649e-01 | 0.318 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.828818e-01 | 0.316 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.850799e-01 | 0.314 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 4.850799e-01 | 0.314 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.912845e-01 | 0.309 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.924601e-01 | 0.308 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 4.932518e-01 | 0.307 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.938274e-01 | 0.306 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.946188e-01 | 0.306 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.951445e-01 | 0.305 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.954366e-01 | 0.305 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 4.954366e-01 | 0.305 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.954366e-01 | 0.305 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.954366e-01 | 0.305 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 4.954366e-01 | 0.305 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.954366e-01 | 0.305 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.954366e-01 | 0.305 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.015554e-01 | 0.300 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.017205e-01 | 0.300 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 5.017205e-01 | 0.300 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 5.017205e-01 | 0.300 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.017205e-01 | 0.300 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.021553e-01 | 0.299 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 5.022787e-01 | 0.299 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.023561e-01 | 0.299 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.023783e-01 | 0.299 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 5.023783e-01 | 0.299 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 5.152331e-01 | 0.288 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.173175e-01 | 0.286 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.173175e-01 | 0.286 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 5.180100e-01 | 0.286 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 5.180100e-01 | 0.286 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 5.180100e-01 | 0.286 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 5.180100e-01 | 0.286 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.180100e-01 | 0.286 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.180100e-01 | 0.286 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.197915e-01 | 0.284 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 5.213113e-01 | 0.283 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.213113e-01 | 0.283 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.213113e-01 | 0.283 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.213113e-01 | 0.283 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 5.213113e-01 | 0.283 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 5.213113e-01 | 0.283 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 5.213113e-01 | 0.283 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.213113e-01 | 0.283 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 5.279297e-01 | 0.277 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 5.279297e-01 | 0.277 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.279297e-01 | 0.277 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 5.310090e-01 | 0.275 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.312696e-01 | 0.275 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.339407e-01 | 0.273 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.339407e-01 | 0.273 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.339407e-01 | 0.273 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.339407e-01 | 0.273 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.339407e-01 | 0.273 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.339407e-01 | 0.273 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.404391e-01 | 0.267 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.407646e-01 | 0.267 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 5.407646e-01 | 0.267 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.423530e-01 | 0.266 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 5.456266e-01 | 0.263 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.457702e-01 | 0.263 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 5.457702e-01 | 0.263 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.458606e-01 | 0.263 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 5.458606e-01 | 0.263 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 5.458606e-01 | 0.263 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 5.458606e-01 | 0.263 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 5.458606e-01 | 0.263 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.458606e-01 | 0.263 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.458606e-01 | 0.263 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.458606e-01 | 0.263 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.458606e-01 | 0.263 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 5.495066e-01 | 0.260 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 5.495066e-01 | 0.260 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.495066e-01 | 0.260 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.495066e-01 | 0.260 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.495066e-01 | 0.260 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 5.509312e-01 | 0.259 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.552086e-01 | 0.256 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.552086e-01 | 0.256 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 5.647032e-01 | 0.248 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 5.647032e-01 | 0.248 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.647032e-01 | 0.248 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.665058e-01 | 0.247 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 5.665058e-01 | 0.247 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.691523e-01 | 0.245 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.691523e-01 | 0.245 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.691523e-01 | 0.245 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.691523e-01 | 0.245 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.691523e-01 | 0.245 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 5.691523e-01 | 0.245 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.691523e-01 | 0.245 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.691523e-01 | 0.245 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.691523e-01 | 0.245 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.691523e-01 | 0.245 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.691523e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.691523e-01 | 0.245 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.691523e-01 | 0.245 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.691523e-01 | 0.245 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.761247e-01 | 0.239 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.767892e-01 | 0.239 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.767892e-01 | 0.239 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.767892e-01 | 0.239 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.795274e-01 | 0.237 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.795274e-01 | 0.237 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.795274e-01 | 0.237 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.795274e-01 | 0.237 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.868165e-01 | 0.231 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.868443e-01 | 0.231 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.868443e-01 | 0.231 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.876066e-01 | 0.231 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 5.912508e-01 | 0.228 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.912508e-01 | 0.228 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 5.912508e-01 | 0.228 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 5.912508e-01 | 0.228 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 5.912508e-01 | 0.228 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.939774e-01 | 0.226 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.968023e-01 | 0.224 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 5.999961e-01 | 0.222 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.999961e-01 | 0.222 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.999961e-01 | 0.222 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.049819e-01 | 0.218 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.080527e-01 | 0.216 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.080527e-01 | 0.216 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.080527e-01 | 0.216 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.080527e-01 | 0.216 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 6.080527e-01 | 0.216 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.080527e-01 | 0.216 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.080527e-01 | 0.216 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.080527e-01 | 0.216 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 6.112814e-01 | 0.214 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.112814e-01 | 0.214 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.117243e-01 | 0.213 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.122171e-01 | 0.213 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 6.122171e-01 | 0.213 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.122171e-01 | 0.213 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 6.122171e-01 | 0.213 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 6.122171e-01 | 0.213 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 6.122171e-01 | 0.213 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.122171e-01 | 0.213 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 6.122171e-01 | 0.213 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.162820e-01 | 0.210 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 6.182039e-01 | 0.209 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.217536e-01 | 0.206 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 6.217536e-01 | 0.206 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 6.223513e-01 | 0.206 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.257988e-01 | 0.204 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.321092e-01 | 0.199 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.321092e-01 | 0.199 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 6.321092e-01 | 0.199 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.321092e-01 | 0.199 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.321092e-01 | 0.199 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 6.321092e-01 | 0.199 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 6.321092e-01 | 0.199 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.321092e-01 | 0.199 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 6.321092e-01 | 0.199 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.321092e-01 | 0.199 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.321092e-01 | 0.199 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 6.321092e-01 | 0.199 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.350815e-01 | 0.197 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 6.350815e-01 | 0.197 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 6.350815e-01 | 0.197 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.350815e-01 | 0.197 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.350815e-01 | 0.197 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 6.350815e-01 | 0.197 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.351643e-01 | 0.197 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.372540e-01 | 0.196 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.438379e-01 | 0.191 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.443768e-01 | 0.191 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.448371e-01 | 0.191 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.475227e-01 | 0.189 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.480386e-01 | 0.188 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 6.480386e-01 | 0.188 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 6.480386e-01 | 0.188 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 6.480386e-01 | 0.188 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.509820e-01 | 0.186 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 6.509820e-01 | 0.186 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.509820e-01 | 0.186 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.509820e-01 | 0.186 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 6.509820e-01 | 0.186 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.509820e-01 | 0.186 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.509820e-01 | 0.186 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 6.509820e-01 | 0.186 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.509820e-01 | 0.186 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.509820e-01 | 0.186 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.509820e-01 | 0.186 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.509820e-01 | 0.186 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 6.509820e-01 | 0.186 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.542522e-01 | 0.184 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.606279e-01 | 0.180 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.606279e-01 | 0.180 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 6.606279e-01 | 0.180 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 6.606279e-01 | 0.180 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.606809e-01 | 0.180 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.623371e-01 | 0.179 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 6.623371e-01 | 0.179 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.623371e-01 | 0.179 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 6.644463e-01 | 0.178 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.688877e-01 | 0.175 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.688877e-01 | 0.175 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 6.688877e-01 | 0.175 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.688877e-01 | 0.175 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.688877e-01 | 0.175 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.688877e-01 | 0.175 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 6.688877e-01 | 0.175 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.688877e-01 | 0.175 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 6.688877e-01 | 0.175 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.688877e-01 | 0.175 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.688877e-01 | 0.175 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.688877e-01 | 0.175 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 6.688877e-01 | 0.175 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 6.688877e-01 | 0.175 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 6.688877e-01 | 0.175 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.707710e-01 | 0.173 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.710828e-01 | 0.173 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 6.728530e-01 | 0.172 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.728530e-01 | 0.172 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 6.728530e-01 | 0.172 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.728530e-01 | 0.172 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 6.728530e-01 | 0.172 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.766972e-01 | 0.170 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.785163e-01 | 0.168 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 6.841736e-01 | 0.165 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.847181e-01 | 0.164 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 6.858758e-01 | 0.164 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 6.858758e-01 | 0.164 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 6.858758e-01 | 0.164 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.858758e-01 | 0.164 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.860998e-01 | 0.164 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.889381e-01 | 0.162 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.962280e-01 | 0.157 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 6.962280e-01 | 0.157 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 6.962280e-01 | 0.157 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.963744e-01 | 0.157 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 7.008839e-01 | 0.154 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 7.019933e-01 | 0.154 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.019933e-01 | 0.154 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.019933e-01 | 0.154 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 7.019933e-01 | 0.154 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.019933e-01 | 0.154 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 7.030226e-01 | 0.153 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.030226e-01 | 0.153 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 7.044887e-01 | 0.152 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.073879e-01 | 0.150 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.073879e-01 | 0.150 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 7.073879e-01 | 0.150 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.073879e-01 | 0.150 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.073879e-01 | 0.150 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.121200e-01 | 0.147 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.124449e-01 | 0.147 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.125307e-01 | 0.147 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.172848e-01 | 0.144 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.172848e-01 | 0.144 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.172848e-01 | 0.144 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 7.172848e-01 | 0.144 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.172848e-01 | 0.144 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 7.172848e-01 | 0.144 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.172848e-01 | 0.144 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.182033e-01 | 0.144 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.182033e-01 | 0.144 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.182033e-01 | 0.144 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.196366e-01 | 0.143 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.210010e-01 | 0.142 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.278841e-01 | 0.138 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.286803e-01 | 0.137 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.292785e-01 | 0.137 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.317925e-01 | 0.136 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 7.317925e-01 | 0.136 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 7.317925e-01 | 0.136 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 7.317925e-01 | 0.136 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 7.317925e-01 | 0.136 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 7.317925e-01 | 0.136 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.317925e-01 | 0.136 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.317925e-01 | 0.136 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 7.317925e-01 | 0.136 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 7.317925e-01 | 0.136 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.317925e-01 | 0.136 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.317925e-01 | 0.136 | 0 | 0 |
| Keratan sulfate degradation | R-HSA-2022857 | 7.317925e-01 | 0.136 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.317925e-01 | 0.136 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 7.381207e-01 | 0.132 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.388250e-01 | 0.131 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.388250e-01 | 0.131 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.445129e-01 | 0.128 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 7.455565e-01 | 0.128 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.455565e-01 | 0.128 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.455565e-01 | 0.128 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 7.455565e-01 | 0.128 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.455565e-01 | 0.128 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.455565e-01 | 0.128 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 7.455565e-01 | 0.128 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.486440e-01 | 0.126 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.486440e-01 | 0.126 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 7.491655e-01 | 0.125 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 7.543974e-01 | 0.122 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.581440e-01 | 0.120 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 7.581440e-01 | 0.120 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 7.581440e-01 | 0.120 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 7.581440e-01 | 0.120 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 7.586150e-01 | 0.120 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.586150e-01 | 0.120 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.586150e-01 | 0.120 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 7.586150e-01 | 0.120 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.673318e-01 | 0.115 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 7.673318e-01 | 0.115 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.673318e-01 | 0.115 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.673318e-01 | 0.115 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.673318e-01 | 0.115 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.710041e-01 | 0.113 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.710041e-01 | 0.113 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.710041e-01 | 0.113 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.710041e-01 | 0.113 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.710041e-01 | 0.113 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.710041e-01 | 0.113 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 7.710041e-01 | 0.113 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.710041e-01 | 0.113 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.710041e-01 | 0.113 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.762144e-01 | 0.110 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.762144e-01 | 0.110 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.762144e-01 | 0.110 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.762144e-01 | 0.110 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.762144e-01 | 0.110 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.762144e-01 | 0.110 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.762144e-01 | 0.110 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 7.772735e-01 | 0.109 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.772735e-01 | 0.109 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.808221e-01 | 0.107 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.827580e-01 | 0.106 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 7.827580e-01 | 0.106 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.827580e-01 | 0.106 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 7.827580e-01 | 0.106 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 7.842316e-01 | 0.106 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.844992e-01 | 0.105 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.847990e-01 | 0.105 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.897088e-01 | 0.103 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 7.915300e-01 | 0.102 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 7.915300e-01 | 0.102 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 7.930927e-01 | 0.101 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.930927e-01 | 0.101 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 7.939092e-01 | 0.100 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.939092e-01 | 0.100 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.939092e-01 | 0.100 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.939092e-01 | 0.100 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.939092e-01 | 0.100 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.968765e-01 | 0.099 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.983688e-01 | 0.098 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.016551e-01 | 0.096 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 8.044887e-01 | 0.094 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 8.044887e-01 | 0.094 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 8.044887e-01 | 0.094 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.044887e-01 | 0.094 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 8.044887e-01 | 0.094 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 8.044887e-01 | 0.094 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.044887e-01 | 0.094 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 8.044887e-01 | 0.094 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.044887e-01 | 0.094 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.044887e-01 | 0.094 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.044887e-01 | 0.094 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.044887e-01 | 0.094 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.088364e-01 | 0.092 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.114836e-01 | 0.091 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.143958e-01 | 0.089 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.145258e-01 | 0.089 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.145258e-01 | 0.089 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.145258e-01 | 0.089 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.145258e-01 | 0.089 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.145258e-01 | 0.089 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.145258e-01 | 0.089 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.145258e-01 | 0.089 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.145258e-01 | 0.089 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.145258e-01 | 0.089 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.163010e-01 | 0.088 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 8.177661e-01 | 0.087 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.235036e-01 | 0.084 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 8.235036e-01 | 0.084 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 8.235036e-01 | 0.084 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.235036e-01 | 0.084 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 8.235036e-01 | 0.084 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.235036e-01 | 0.084 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 8.238697e-01 | 0.084 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.240481e-01 | 0.084 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.240481e-01 | 0.084 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 8.240481e-01 | 0.084 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 8.240481e-01 | 0.084 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.257823e-01 | 0.083 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.304515e-01 | 0.081 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.304515e-01 | 0.081 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 8.304515e-01 | 0.081 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.330821e-01 | 0.079 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 8.330821e-01 | 0.079 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 8.355541e-01 | 0.078 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.416528e-01 | 0.075 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.416528e-01 | 0.075 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.436118e-01 | 0.074 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 8.436118e-01 | 0.074 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 8.444121e-01 | 0.073 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 8.465647e-01 | 0.072 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.497838e-01 | 0.071 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 8.497838e-01 | 0.071 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.497838e-01 | 0.071 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 8.497838e-01 | 0.071 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.498383e-01 | 0.071 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.546156e-01 | 0.068 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.574979e-01 | 0.067 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.574979e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.574979e-01 | 0.067 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.585729e-01 | 0.066 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.585729e-01 | 0.066 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 8.616185e-01 | 0.065 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.616185e-01 | 0.065 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.628624e-01 | 0.064 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 8.648162e-01 | 0.063 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.648162e-01 | 0.063 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.671352e-01 | 0.062 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.671858e-01 | 0.062 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.713266e-01 | 0.060 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.714192e-01 | 0.060 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 8.717591e-01 | 0.060 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.717591e-01 | 0.060 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.717591e-01 | 0.060 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.717591e-01 | 0.060 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.717591e-01 | 0.060 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.717591e-01 | 0.060 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 8.717591e-01 | 0.060 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 8.725468e-01 | 0.059 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.725468e-01 | 0.059 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.725468e-01 | 0.059 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 8.725468e-01 | 0.059 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 8.758332e-01 | 0.058 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.774632e-01 | 0.057 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.774632e-01 | 0.057 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.777079e-01 | 0.057 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 8.783459e-01 | 0.056 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.783459e-01 | 0.056 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 8.783459e-01 | 0.056 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.783459e-01 | 0.056 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.783459e-01 | 0.056 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.783459e-01 | 0.056 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 8.783459e-01 | 0.056 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.820300e-01 | 0.055 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.826756e-01 | 0.054 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 8.845947e-01 | 0.053 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.845947e-01 | 0.053 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.845947e-01 | 0.053 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.845947e-01 | 0.053 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.845947e-01 | 0.053 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.863088e-01 | 0.052 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.874560e-01 | 0.052 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.905229e-01 | 0.050 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.905229e-01 | 0.050 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 8.905229e-01 | 0.050 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.961469e-01 | 0.048 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.961469e-01 | 0.048 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 8.961469e-01 | 0.048 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.961469e-01 | 0.048 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 8.961469e-01 | 0.048 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.014823e-01 | 0.045 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.014823e-01 | 0.045 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.014823e-01 | 0.045 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.014823e-01 | 0.045 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.014823e-01 | 0.045 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 9.014823e-01 | 0.045 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.014823e-01 | 0.045 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.048258e-01 | 0.043 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.051580e-01 | 0.043 | 0 | 0 |
| Translation | R-HSA-72766 | 9.053543e-01 | 0.043 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 9.065439e-01 | 0.043 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.065439e-01 | 0.043 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.065439e-01 | 0.043 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.065439e-01 | 0.043 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.072237e-01 | 0.042 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.086838e-01 | 0.042 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.104758e-01 | 0.041 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.113458e-01 | 0.040 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.113458e-01 | 0.040 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.113458e-01 | 0.040 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.159012e-01 | 0.038 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.159012e-01 | 0.038 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.161733e-01 | 0.038 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 9.161733e-01 | 0.038 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.196646e-01 | 0.036 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.196646e-01 | 0.036 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.196646e-01 | 0.036 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.196646e-01 | 0.036 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.196646e-01 | 0.036 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.202228e-01 | 0.036 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.202228e-01 | 0.036 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.202228e-01 | 0.036 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.202228e-01 | 0.036 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.243226e-01 | 0.034 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.243226e-01 | 0.034 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.243226e-01 | 0.034 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.256887e-01 | 0.034 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.262407e-01 | 0.033 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.262407e-01 | 0.033 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.275573e-01 | 0.033 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.282119e-01 | 0.032 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.293350e-01 | 0.032 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.323064e-01 | 0.030 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.323064e-01 | 0.030 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.354018e-01 | 0.029 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.354018e-01 | 0.029 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.354018e-01 | 0.029 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.387223e-01 | 0.027 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 9.387223e-01 | 0.027 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.387223e-01 | 0.027 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.405267e-01 | 0.027 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.405267e-01 | 0.027 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.405267e-01 | 0.027 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.418723e-01 | 0.026 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.418723e-01 | 0.026 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.448606e-01 | 0.025 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.448606e-01 | 0.025 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.448606e-01 | 0.025 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.457449e-01 | 0.024 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 9.476954e-01 | 0.023 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.476954e-01 | 0.023 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.503847e-01 | 0.022 | 0 | 0 |
| Keratan sulfate/keratin metabolism | R-HSA-1638074 | 9.503847e-01 | 0.022 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.511647e-01 | 0.022 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.521583e-01 | 0.021 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.529358e-01 | 0.021 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.553559e-01 | 0.020 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.553559e-01 | 0.020 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.553559e-01 | 0.020 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.576517e-01 | 0.019 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.582395e-01 | 0.019 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.598296e-01 | 0.018 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.598296e-01 | 0.018 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.618956e-01 | 0.017 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.638555e-01 | 0.016 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.674783e-01 | 0.014 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.691513e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.705766e-01 | 0.013 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.707384e-01 | 0.013 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.707384e-01 | 0.013 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.718613e-01 | 0.012 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.718613e-01 | 0.012 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.722439e-01 | 0.012 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.736720e-01 | 0.012 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.736720e-01 | 0.012 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.750267e-01 | 0.011 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.758368e-01 | 0.011 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.764795e-01 | 0.010 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.775309e-01 | 0.010 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.816326e-01 | 0.008 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.818117e-01 | 0.008 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.836362e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.840715e-01 | 0.007 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.844787e-01 | 0.007 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.844787e-01 | 0.007 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.852778e-01 | 0.006 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.852778e-01 | 0.006 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.860359e-01 | 0.006 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.874370e-01 | 0.005 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.886977e-01 | 0.005 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.887539e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.892798e-01 | 0.005 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.903342e-01 | 0.004 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.908526e-01 | 0.004 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.908526e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.913771e-01 | 0.004 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.921949e-01 | 0.003 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.930981e-01 | 0.003 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.936836e-01 | 0.003 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.939629e-01 | 0.003 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.940091e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.946108e-01 | 0.002 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.949573e-01 | 0.002 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.949993e-01 | 0.002 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.954021e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.958640e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.964847e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.969897e-01 | 0.001 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.980997e-01 | 0.001 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.982159e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.984060e-01 | 0.001 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.984106e-01 | 0.001 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.984883e-01 | 0.001 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.984922e-01 | 0.001 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.985552e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.986225e-01 | 0.001 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.989856e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.991237e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.992804e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.993203e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.994847e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.995037e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.995767e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.997081e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.997988e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.998753e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.998892e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999308e-01 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 9.999438e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999464e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999703e-01 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.999806e-01 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.999848e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999875e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999935e-01 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.999961e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999994e-01 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.110223e-16 | 15.955 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.110223e-16 | 15.955 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.110223e-16 | 15.955 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.220446e-16 | 15.654 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.220446e-16 | 15.654 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.330669e-16 | 15.477 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.332268e-15 | 14.875 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.476597e-14 | 13.831 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.831069e-14 | 13.548 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.985701e-14 | 13.399 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.044720e-13 | 12.981 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.038059e-13 | 12.984 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.190159e-13 | 12.924 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.274536e-13 | 12.895 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.910694e-13 | 12.719 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.771117e-13 | 12.557 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.395062e-13 | 12.469 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 4.239942e-13 | 12.373 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.707657e-13 | 12.244 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.676881e-13 | 12.175 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.114620e-13 | 12.091 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.114620e-13 | 12.091 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.633693e-12 | 11.787 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.664224e-12 | 11.779 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.707967e-12 | 11.768 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.388756e-12 | 11.622 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.235856e-12 | 11.490 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.460166e-12 | 11.190 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.202927e-11 | 10.920 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.414158e-11 | 10.850 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.547329e-11 | 10.810 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.949607e-11 | 10.710 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 2.320177e-11 | 10.634 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 2.581846e-11 | 10.588 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.760558e-11 | 10.559 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.873213e-11 | 10.542 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.972345e-11 | 10.527 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.919543e-11 | 10.228 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.130963e-11 | 10.039 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.917123e-11 | 10.050 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.428502e-11 | 10.026 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.239301e-10 | 9.907 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 3.092981e-10 | 9.510 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 4.114131e-10 | 9.386 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.547500e-10 | 9.342 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.152633e-10 | 9.288 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.046435e-10 | 9.152 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.209459e-09 | 8.917 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.203730e-09 | 8.919 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 1.246614e-09 | 8.904 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.292609e-09 | 8.889 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.319754e-09 | 8.880 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 1.419497e-09 | 8.848 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.757492e-09 | 8.755 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.106510e-09 | 8.676 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.326390e-09 | 8.633 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.881639e-09 | 8.540 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.065777e-09 | 8.513 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.663936e-09 | 8.436 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.067545e-09 | 8.391 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.530612e-09 | 8.257 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.530612e-09 | 8.257 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.744950e-09 | 8.171 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.453742e-09 | 8.128 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.667661e-09 | 8.015 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.079560e-08 | 7.967 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.534980e-08 | 7.814 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.858497e-08 | 7.731 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.103244e-08 | 7.677 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.036291e-08 | 7.691 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 2.404514e-08 | 7.619 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.807283e-08 | 7.552 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.093281e-08 | 7.510 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.211593e-08 | 7.376 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.216339e-08 | 7.375 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.172444e-08 | 7.144 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 7.791288e-08 | 7.108 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 9.679293e-08 | 7.014 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.912018e-08 | 7.004 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.137510e-07 | 6.944 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.139327e-07 | 6.943 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.463885e-07 | 6.834 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 1.574564e-07 | 6.803 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.736361e-07 | 6.760 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.812412e-07 | 6.742 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.148825e-07 | 6.668 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.213329e-07 | 6.655 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.742120e-07 | 6.562 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 2.770004e-07 | 6.558 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.787500e-07 | 6.422 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.093614e-07 | 6.388 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.843961e-07 | 6.315 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.666494e-07 | 6.176 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 6.392085e-07 | 6.194 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 8.172310e-07 | 6.088 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.676897e-07 | 6.062 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 9.483321e-07 | 6.023 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 9.951921e-07 | 6.002 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.143473e-06 | 5.942 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.245444e-06 | 5.905 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.245444e-06 | 5.905 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.353834e-06 | 5.868 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.583507e-06 | 5.800 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.583507e-06 | 5.800 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.583507e-06 | 5.800 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.583507e-06 | 5.800 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.799610e-06 | 5.745 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.828866e-06 | 5.738 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.837388e-06 | 5.736 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.873103e-06 | 5.727 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.952139e-06 | 5.709 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.210268e-06 | 5.656 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 2.245982e-06 | 5.649 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.562159e-06 | 5.591 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.884520e-06 | 5.540 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.907599e-06 | 5.536 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.575877e-06 | 5.447 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.855214e-06 | 5.414 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.827780e-06 | 5.417 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.108025e-06 | 5.386 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.261970e-06 | 5.370 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.501991e-06 | 5.347 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.533003e-06 | 5.344 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 4.607821e-06 | 5.337 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 4.828372e-06 | 5.316 | 0 | 0 |
| Translation | R-HSA-72766 | 5.616944e-06 | 5.250 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.363226e-06 | 5.271 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.053614e-06 | 5.218 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.392272e-06 | 5.194 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.847355e-06 | 5.164 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.125020e-06 | 5.147 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 8.985482e-06 | 5.046 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.002940e-05 | 4.999 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.050871e-05 | 4.978 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.050871e-05 | 4.978 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.197192e-05 | 4.922 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.204565e-05 | 4.919 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.279872e-05 | 4.893 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.295056e-05 | 4.888 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.692419e-05 | 4.771 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 1.861689e-05 | 4.730 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.026497e-05 | 4.693 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.366762e-05 | 4.626 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.383649e-05 | 4.623 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.519280e-05 | 4.599 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.343930e-05 | 4.476 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.401881e-05 | 4.468 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.481822e-05 | 4.458 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.641036e-05 | 4.439 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.641036e-05 | 4.439 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.784660e-05 | 4.422 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.904239e-05 | 4.408 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.088220e-05 | 4.388 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 4.102789e-05 | 4.387 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 4.106063e-05 | 4.387 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.264330e-05 | 4.370 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 4.577410e-05 | 4.339 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.001106e-05 | 4.301 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.066400e-05 | 4.295 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 5.161425e-05 | 4.287 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 6.028351e-05 | 4.220 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.865979e-05 | 4.163 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 7.523871e-05 | 4.124 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.523871e-05 | 4.124 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 7.654513e-05 | 4.116 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.739437e-05 | 4.111 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.739437e-05 | 4.111 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 7.759743e-05 | 4.110 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.759743e-05 | 4.110 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.953162e-05 | 4.099 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.352154e-05 | 4.029 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 9.582625e-05 | 4.019 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.698339e-05 | 4.013 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.005194e-04 | 3.998 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.005194e-04 | 3.998 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 1.200369e-04 | 3.921 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.234518e-04 | 3.909 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.180333e-04 | 3.928 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.328921e-04 | 3.877 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.328921e-04 | 3.877 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.417085e-04 | 3.849 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.417085e-04 | 3.849 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.435953e-04 | 3.843 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.444578e-04 | 3.840 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.476421e-04 | 3.831 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.545771e-04 | 3.811 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.569058e-04 | 3.804 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.660905e-04 | 3.780 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.679614e-04 | 3.775 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.717590e-04 | 3.765 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.929230e-04 | 3.715 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.104281e-04 | 3.677 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.076110e-04 | 3.683 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.153216e-04 | 3.667 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 1.987836e-04 | 3.702 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.971105e-04 | 3.705 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 2.179316e-04 | 3.662 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.355335e-04 | 3.628 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 2.553345e-04 | 3.593 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 2.579154e-04 | 3.589 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.766866e-04 | 3.558 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.973410e-04 | 3.527 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.096642e-04 | 3.509 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.227096e-04 | 3.491 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.495483e-04 | 3.456 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 3.525568e-04 | 3.453 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 3.702988e-04 | 3.431 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 3.890086e-04 | 3.410 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 3.997282e-04 | 3.398 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 4.038834e-04 | 3.394 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.105916e-04 | 3.387 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.105916e-04 | 3.387 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.138676e-04 | 3.383 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.456369e-04 | 3.351 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.457700e-04 | 3.351 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.457700e-04 | 3.351 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.136711e-04 | 3.289 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.759414e-04 | 3.322 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.619860e-04 | 3.335 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.200951e-04 | 3.284 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.648782e-04 | 3.333 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.592001e-04 | 3.338 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.589854e-04 | 3.338 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.284489e-04 | 3.277 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.457236e-04 | 3.263 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.457236e-04 | 3.263 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.589887e-04 | 3.253 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.637328e-04 | 3.249 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.637328e-04 | 3.249 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.754836e-04 | 3.240 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.079885e-04 | 3.216 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.198353e-04 | 3.208 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.285203e-04 | 3.202 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.285203e-04 | 3.202 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 6.574546e-04 | 3.182 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 6.574546e-04 | 3.182 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 6.574546e-04 | 3.182 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.579943e-04 | 3.182 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 6.586047e-04 | 3.181 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.689329e-04 | 3.175 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.830829e-04 | 3.166 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.117707e-04 | 3.148 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.506607e-04 | 3.125 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.838034e-04 | 3.106 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.838034e-04 | 3.106 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 7.933408e-04 | 3.101 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 7.933408e-04 | 3.101 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 9.415375e-04 | 3.026 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.920210e-04 | 3.050 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 8.112709e-04 | 3.091 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.457639e-04 | 3.073 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 9.289206e-04 | 3.032 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.680858e-04 | 3.061 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.879417e-04 | 3.052 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 9.426102e-04 | 3.026 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.606789e-04 | 3.065 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.897628e-04 | 3.004 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.013420e-03 | 2.994 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.027986e-03 | 2.988 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.027986e-03 | 2.988 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.057125e-03 | 2.976 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.057125e-03 | 2.976 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.066600e-03 | 2.972 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.075743e-03 | 2.968 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.105030e-03 | 2.957 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.151165e-03 | 2.939 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.160773e-03 | 2.935 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.184225e-03 | 2.927 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.190534e-03 | 2.924 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.202349e-03 | 2.920 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.242986e-03 | 2.906 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.242986e-03 | 2.906 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.258377e-03 | 2.900 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.264148e-03 | 2.898 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.264148e-03 | 2.898 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.302103e-03 | 2.885 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.308462e-03 | 2.883 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.341088e-03 | 2.873 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.378372e-03 | 2.861 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.396378e-03 | 2.855 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.509930e-03 | 2.821 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.509930e-03 | 2.821 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.509930e-03 | 2.821 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.541187e-03 | 2.812 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.564737e-03 | 2.806 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.575313e-03 | 2.803 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.575313e-03 | 2.803 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.584427e-03 | 2.800 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.584427e-03 | 2.800 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.584427e-03 | 2.800 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.584427e-03 | 2.800 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.588144e-03 | 2.799 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.603169e-03 | 2.795 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 1.719446e-03 | 2.765 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.726900e-03 | 2.763 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.101213e-03 | 2.678 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 1.907141e-03 | 2.720 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.882998e-03 | 2.725 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.907739e-03 | 2.719 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 2.205003e-03 | 2.657 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 2.226513e-03 | 2.652 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.289741e-03 | 2.640 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.289741e-03 | 2.640 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.289741e-03 | 2.640 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.344416e-03 | 2.630 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.344837e-03 | 2.630 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.384918e-03 | 2.623 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.400646e-03 | 2.620 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.434564e-03 | 2.614 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.461226e-03 | 2.609 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.501933e-03 | 2.602 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.549083e-03 | 2.594 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.558897e-03 | 2.592 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 2.558897e-03 | 2.592 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 2.581188e-03 | 2.588 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.603061e-03 | 2.585 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.603061e-03 | 2.585 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.648040e-03 | 2.577 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.648040e-03 | 2.577 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.752842e-03 | 2.560 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.822659e-03 | 2.549 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.822659e-03 | 2.549 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 2.884765e-03 | 2.540 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 2.898526e-03 | 2.538 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.992593e-03 | 2.524 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.199172e-03 | 2.495 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.255194e-03 | 2.487 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.281093e-03 | 2.484 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.516418e-03 | 2.454 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.595655e-03 | 2.444 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.598363e-03 | 2.444 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 3.775578e-03 | 2.423 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 3.776130e-03 | 2.423 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.901855e-03 | 2.409 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.015162e-03 | 2.396 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.116460e-03 | 2.385 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.139423e-03 | 2.383 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.139423e-03 | 2.383 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 4.253148e-03 | 2.371 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.377224e-03 | 2.359 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.382259e-03 | 2.358 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.434222e-03 | 2.353 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.446573e-03 | 2.352 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 4.446573e-03 | 2.352 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 4.602265e-03 | 2.337 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.661243e-03 | 2.331 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 4.754979e-03 | 2.323 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.786309e-03 | 2.320 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 4.786541e-03 | 2.320 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.826549e-03 | 2.316 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 4.842522e-03 | 2.315 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 5.315950e-03 | 2.274 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.697010e-03 | 2.244 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.291477e-03 | 2.276 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.992417e-03 | 2.222 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 6.081527e-03 | 2.216 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.920984e-03 | 2.308 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 5.049078e-03 | 2.297 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 5.049078e-03 | 2.297 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 5.162207e-03 | 2.287 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.081527e-03 | 2.216 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.863479e-03 | 2.232 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.463312e-03 | 2.263 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.452526e-03 | 2.263 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.446352e-03 | 2.264 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.697010e-03 | 2.244 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.073236e-03 | 2.217 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.171139e-03 | 2.210 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.282204e-03 | 2.202 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.344694e-03 | 2.198 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 6.344694e-03 | 2.198 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.365287e-03 | 2.196 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.554154e-03 | 2.183 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.554154e-03 | 2.183 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 6.615470e-03 | 2.179 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.667005e-03 | 2.176 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.071107e-03 | 2.151 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.241145e-03 | 2.140 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.248084e-03 | 2.140 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.638057e-03 | 2.117 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 7.748491e-03 | 2.111 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 8.050375e-03 | 2.094 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.050375e-03 | 2.094 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.161304e-03 | 2.088 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.161304e-03 | 2.088 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 8.298020e-03 | 2.081 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.327108e-03 | 2.080 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.858848e-03 | 2.053 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.879749e-03 | 2.052 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.943774e-03 | 2.048 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.943774e-03 | 2.048 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.204431e-03 | 2.036 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.240859e-03 | 2.034 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 9.265472e-03 | 2.033 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.536094e-03 | 2.021 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 9.536094e-03 | 2.021 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 9.536094e-03 | 2.021 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 9.539099e-03 | 2.020 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 9.554118e-03 | 2.020 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.554118e-03 | 2.020 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 9.554118e-03 | 2.020 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 9.652567e-03 | 2.015 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 9.686415e-03 | 2.014 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.772377e-03 | 2.010 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.772377e-03 | 2.010 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 9.901036e-03 | 2.004 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.099810e-02 | 1.959 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.176146e-02 | 1.930 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.176146e-02 | 1.930 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.176955e-02 | 1.929 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.178479e-02 | 1.929 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.227507e-02 | 1.911 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.227507e-02 | 1.911 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 1.233684e-02 | 1.909 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.275284e-02 | 1.894 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.300216e-02 | 1.886 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.303618e-02 | 1.885 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.336171e-02 | 1.874 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 1.336171e-02 | 1.874 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.336171e-02 | 1.874 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 1.336171e-02 | 1.874 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.337971e-02 | 1.874 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.346544e-02 | 1.871 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.356293e-02 | 1.868 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.373789e-02 | 1.862 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.373789e-02 | 1.862 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 1.383607e-02 | 1.859 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 1.385597e-02 | 1.858 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.431239e-02 | 1.844 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 1.431239e-02 | 1.844 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.436132e-02 | 1.843 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.465793e-02 | 1.834 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.465793e-02 | 1.834 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.465793e-02 | 1.834 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.570271e-02 | 1.804 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.964839e-02 | 1.707 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.964839e-02 | 1.707 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 1.823495e-02 | 1.739 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.566291e-02 | 1.805 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.906183e-02 | 1.720 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.712909e-02 | 1.766 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.712909e-02 | 1.766 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 1.743946e-02 | 1.758 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.730931e-02 | 1.762 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.670742e-02 | 1.777 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.655915e-02 | 1.781 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.555187e-02 | 1.808 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.824916e-02 | 1.739 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.670742e-02 | 1.777 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 1.566291e-02 | 1.805 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.559110e-02 | 1.807 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.927171e-02 | 1.715 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.670742e-02 | 1.777 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.956119e-02 | 1.709 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.770534e-02 | 1.752 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.744671e-02 | 1.758 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.920753e-02 | 1.717 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 1.908796e-02 | 1.719 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.495724e-02 | 1.825 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.920753e-02 | 1.717 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.703655e-02 | 1.769 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.736159e-02 | 1.760 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.736159e-02 | 1.760 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.973361e-02 | 1.705 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 1.973361e-02 | 1.705 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.113969e-02 | 1.675 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.113969e-02 | 1.675 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.139420e-02 | 1.670 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.167773e-02 | 1.664 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 2.167773e-02 | 1.664 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.183655e-02 | 1.661 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.183655e-02 | 1.661 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.183655e-02 | 1.661 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.217861e-02 | 1.654 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.224846e-02 | 1.653 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.262447e-02 | 1.645 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.262447e-02 | 1.645 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.262447e-02 | 1.645 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.262447e-02 | 1.645 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.268576e-02 | 1.644 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.289598e-02 | 1.640 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.318515e-02 | 1.635 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.332978e-02 | 1.632 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.344284e-02 | 1.630 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 2.370355e-02 | 1.625 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.370453e-02 | 1.625 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 2.391855e-02 | 1.621 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.435272e-02 | 1.613 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.435272e-02 | 1.613 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.451465e-02 | 1.611 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 2.489908e-02 | 1.604 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.499578e-02 | 1.602 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.508358e-02 | 1.601 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.520040e-02 | 1.599 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.556351e-02 | 1.592 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 2.706367e-02 | 1.568 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.711597e-02 | 1.567 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 2.770860e-02 | 1.557 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.770860e-02 | 1.557 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 2.770860e-02 | 1.557 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 2.790798e-02 | 1.554 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.798705e-02 | 1.553 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.798705e-02 | 1.553 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.818396e-02 | 1.550 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 2.818396e-02 | 1.550 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.818396e-02 | 1.550 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.826471e-02 | 1.549 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.826471e-02 | 1.549 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.826471e-02 | 1.549 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.951532e-02 | 1.530 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 2.951532e-02 | 1.530 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.951532e-02 | 1.530 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.975243e-02 | 1.526 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.991812e-02 | 1.524 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.050815e-02 | 1.516 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.050815e-02 | 1.516 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 3.050815e-02 | 1.516 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.050815e-02 | 1.516 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.050815e-02 | 1.516 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.056195e-02 | 1.515 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.068172e-02 | 1.513 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 3.120532e-02 | 1.506 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.120532e-02 | 1.506 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 3.194811e-02 | 1.496 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.194811e-02 | 1.496 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 3.194811e-02 | 1.496 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.194811e-02 | 1.496 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.194811e-02 | 1.496 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.216544e-02 | 1.493 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.303719e-02 | 1.481 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.384643e-02 | 1.470 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.491822e-02 | 1.457 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.517259e-02 | 1.454 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.517259e-02 | 1.454 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.517259e-02 | 1.454 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 3.547557e-02 | 1.450 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.577407e-02 | 1.446 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 3.577407e-02 | 1.446 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.610876e-02 | 1.442 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.610876e-02 | 1.442 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.612999e-02 | 1.442 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.760058e-02 | 1.425 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 3.785292e-02 | 1.422 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 3.785292e-02 | 1.422 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.815260e-02 | 1.418 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.815260e-02 | 1.418 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.851257e-02 | 1.414 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.851257e-02 | 1.414 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 5.239722e-02 | 1.281 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 5.239722e-02 | 1.281 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.508438e-02 | 1.259 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.508438e-02 | 1.259 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.508438e-02 | 1.259 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.508438e-02 | 1.259 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.694293e-02 | 1.328 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.694293e-02 | 1.328 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 4.786539e-02 | 1.320 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 4.786539e-02 | 1.320 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.891035e-02 | 1.230 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.891035e-02 | 1.230 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 4.566582e-02 | 1.340 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.227219e-02 | 1.374 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 4.980883e-02 | 1.303 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.182302e-02 | 1.285 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 4.078769e-02 | 1.389 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.032302e-02 | 1.394 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.953900e-02 | 1.403 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.746118e-02 | 1.324 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.746118e-02 | 1.324 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.417686e-02 | 1.266 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.246609e-02 | 1.280 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.966276e-02 | 1.402 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.983621e-02 | 1.400 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 4.980883e-02 | 1.303 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.956304e-02 | 1.305 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.508438e-02 | 1.259 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 4.786539e-02 | 1.320 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 4.980883e-02 | 1.303 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 4.012695e-02 | 1.397 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.012695e-02 | 1.397 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.787675e-02 | 1.320 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 5.246609e-02 | 1.280 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.367753e-02 | 1.270 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.787675e-02 | 1.320 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 5.239722e-02 | 1.281 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 4.566582e-02 | 1.340 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.934214e-02 | 1.405 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.136330e-02 | 1.289 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 5.891035e-02 | 1.230 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.246609e-02 | 1.280 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.078612e-02 | 1.389 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.078612e-02 | 1.389 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.503965e-02 | 1.346 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 5.136330e-02 | 1.289 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 4.078769e-02 | 1.389 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.537364e-02 | 1.343 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 4.980883e-02 | 1.303 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.727308e-02 | 1.242 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 4.078769e-02 | 1.389 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.345376e-02 | 1.272 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.484417e-02 | 1.348 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.249053e-02 | 1.280 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.694293e-02 | 1.328 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.891035e-02 | 1.230 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.078769e-02 | 1.389 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 4.626210e-02 | 1.335 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.367753e-02 | 1.270 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 5.814462e-02 | 1.235 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 5.356494e-02 | 1.271 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.336619e-02 | 1.273 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.246609e-02 | 1.280 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.503965e-02 | 1.346 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.367753e-02 | 1.270 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.246609e-02 | 1.280 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 5.136330e-02 | 1.289 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.163135e-02 | 1.381 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.956304e-02 | 1.305 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 4.694293e-02 | 1.328 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.907847e-02 | 1.229 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.945598e-02 | 1.226 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.947320e-02 | 1.226 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 6.063591e-02 | 1.217 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.063591e-02 | 1.217 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.143415e-02 | 1.212 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 6.143415e-02 | 1.212 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.281722e-02 | 1.202 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.354671e-02 | 1.197 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 6.364429e-02 | 1.196 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 6.427367e-02 | 1.192 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.480334e-02 | 1.188 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 6.557885e-02 | 1.183 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 6.557885e-02 | 1.183 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 6.557885e-02 | 1.183 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.656391e-02 | 1.177 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.705323e-02 | 1.174 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.705323e-02 | 1.174 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.729137e-02 | 1.172 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.767548e-02 | 1.170 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 6.767548e-02 | 1.170 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.767548e-02 | 1.170 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.777924e-02 | 1.169 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.777924e-02 | 1.169 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.777924e-02 | 1.169 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.044511e-02 | 1.152 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.128687e-02 | 1.147 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.128687e-02 | 1.147 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.128687e-02 | 1.147 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.301400e-02 | 1.137 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 7.539902e-02 | 1.123 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 7.539902e-02 | 1.123 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 7.589219e-02 | 1.120 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.589219e-02 | 1.120 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.589219e-02 | 1.120 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.620757e-02 | 1.118 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 7.620757e-02 | 1.118 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.620757e-02 | 1.118 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.677368e-02 | 1.115 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 7.725405e-02 | 1.112 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 7.725405e-02 | 1.112 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.725405e-02 | 1.112 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.095720e-02 | 1.092 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 8.166733e-02 | 1.088 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.309761e-02 | 1.080 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 8.395629e-02 | 1.076 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.497533e-02 | 1.071 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.497533e-02 | 1.071 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.497533e-02 | 1.071 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.497533e-02 | 1.071 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.497533e-02 | 1.071 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 8.615397e-02 | 1.065 | 0 | 0 |
| Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK) | R-HSA-1299308 | 8.615397e-02 | 1.065 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 8.615397e-02 | 1.065 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.644934e-02 | 1.063 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 8.798738e-02 | 1.056 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.798738e-02 | 1.056 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.798738e-02 | 1.056 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.807940e-02 | 1.055 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.085453e-02 | 1.042 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.328316e-02 | 1.030 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 9.357825e-02 | 1.029 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.680321e-02 | 1.014 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.680321e-02 | 1.014 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.694196e-02 | 1.013 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.837423e-02 | 1.007 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 9.850586e-02 | 1.007 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 9.850586e-02 | 1.007 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 9.850586e-02 | 1.007 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 9.850586e-02 | 1.007 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 9.961322e-02 | 1.002 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.993874e-02 | 1.000 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 9.993874e-02 | 1.000 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 9.993874e-02 | 1.000 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 9.993874e-02 | 1.000 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.006652e-01 | 0.997 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.069220e-01 | 0.971 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.078277e-01 | 0.967 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.078277e-01 | 0.967 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.078450e-01 | 0.967 | 0 | 0 |
| Drug resistance of FLT3 mutants | R-HSA-9702506 | 1.145490e-01 | 0.941 | 0 | 0 |
| FLT3 mutants bind TKIs | R-HSA-9702509 | 1.145490e-01 | 0.941 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.145490e-01 | 0.941 | 0 | 0 |
| midostaurin-resistant FLT3 mutants | R-HSA-9702600 | 1.145490e-01 | 0.941 | 0 | 0 |
| quizartinib-resistant FLT3 mutants | R-HSA-9702620 | 1.145490e-01 | 0.941 | 0 | 0 |
| tandutinib-resistant FLT3 mutants | R-HSA-9702636 | 1.145490e-01 | 0.941 | 0 | 0 |
| sorafenib-resistant FLT3 mutants | R-HSA-9702624 | 1.145490e-01 | 0.941 | 0 | 0 |
| tamatinib-resistant FLT3 mutants | R-HSA-9703009 | 1.145490e-01 | 0.941 | 0 | 0 |
| pexidartinib-resistant FLT3 mutants | R-HSA-9702605 | 1.145490e-01 | 0.941 | 0 | 0 |
| ponatinib-resistant FLT3 mutants | R-HSA-9702614 | 1.145490e-01 | 0.941 | 0 | 0 |
| crenolanib-resistant FLT3 mutants | R-HSA-9702581 | 1.145490e-01 | 0.941 | 0 | 0 |
| gilteritinib-resistant FLT3 mutants | R-HSA-9702590 | 1.145490e-01 | 0.941 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.145490e-01 | 0.941 | 0 | 0 |
| lestaurtinib-resistant FLT3 mutants | R-HSA-9702596 | 1.145490e-01 | 0.941 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.145490e-01 | 0.941 | 0 | 0 |
| KW2449-resistant FLT3 mutants | R-HSA-9702569 | 1.145490e-01 | 0.941 | 0 | 0 |
| semaxanib-resistant FLT3 mutants | R-HSA-9702577 | 1.145490e-01 | 0.941 | 0 | 0 |
| sunitinib-resistant FLT3 mutants | R-HSA-9702632 | 1.145490e-01 | 0.941 | 0 | 0 |
| linifanib-resistant FLT3 mutants | R-HSA-9702998 | 1.145490e-01 | 0.941 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 2.159824e-01 | 0.666 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.159824e-01 | 0.666 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.159824e-01 | 0.666 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.159824e-01 | 0.666 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 2.159824e-01 | 0.666 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.159824e-01 | 0.666 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.159824e-01 | 0.666 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.159824e-01 | 0.666 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 2.159824e-01 | 0.666 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.159824e-01 | 0.666 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.246125e-01 | 0.904 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 1.246125e-01 | 0.904 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.246125e-01 | 0.904 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.662537e-01 | 0.779 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.662537e-01 | 0.779 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.662537e-01 | 0.779 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 1.662537e-01 | 0.779 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.240668e-01 | 0.906 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 1.240668e-01 | 0.906 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 1.240668e-01 | 0.906 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.240668e-01 | 0.906 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 2.098449e-01 | 0.678 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 2.098449e-01 | 0.678 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.098449e-01 | 0.678 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 2.098449e-01 | 0.678 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 2.098449e-01 | 0.678 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.098449e-01 | 0.678 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.517195e-01 | 0.819 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.517195e-01 | 0.819 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.517195e-01 | 0.819 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.517195e-01 | 0.819 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.126388e-01 | 0.948 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.810949e-01 | 0.742 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.810949e-01 | 0.742 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 1.810949e-01 | 0.742 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.810949e-01 | 0.742 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.810949e-01 | 0.742 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.161245e-01 | 0.935 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.161245e-01 | 0.935 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 1.552821e-01 | 0.809 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.552821e-01 | 0.809 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.552821e-01 | 0.809 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.552821e-01 | 0.809 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 2.118300e-01 | 0.674 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.118300e-01 | 0.674 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 2.118300e-01 | 0.674 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 2.118300e-01 | 0.674 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 1.334664e-01 | 0.875 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.334664e-01 | 0.875 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.151144e-01 | 0.939 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.518867e-01 | 0.818 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.518867e-01 | 0.818 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.119863e-01 | 0.951 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.119863e-01 | 0.951 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 2.028983e-01 | 0.693 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 2.028983e-01 | 0.693 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.028983e-01 | 0.693 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.712983e-01 | 0.766 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.390149e-01 | 0.857 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.318368e-01 | 0.880 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.536119e-01 | 0.814 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.536119e-01 | 0.814 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.127120e-01 | 0.672 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.127120e-01 | 0.672 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.247185e-01 | 0.904 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.363167e-01 | 0.865 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.282849e-01 | 0.892 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.847890e-01 | 0.733 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.484514e-01 | 0.828 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.484514e-01 | 0.828 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.484514e-01 | 0.828 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.169959e-01 | 0.664 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.169959e-01 | 0.664 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.169959e-01 | 0.664 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.742535e-01 | 0.759 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.170349e-01 | 0.932 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.179158e-01 | 0.662 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.179158e-01 | 0.662 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.019479e-01 | 0.695 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.007508e-01 | 0.697 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.142768e-01 | 0.669 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.447850e-01 | 0.839 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.127120e-01 | 0.672 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.871092e-01 | 0.728 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.300818e-01 | 0.886 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 1.760247e-01 | 0.754 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.800481e-01 | 0.745 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 1.800481e-01 | 0.745 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 1.583319e-01 | 0.800 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.126388e-01 | 0.948 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.178178e-01 | 0.929 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.118300e-01 | 0.674 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.662537e-01 | 0.779 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 2.098449e-01 | 0.678 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.112103e-01 | 0.954 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 1.119863e-01 | 0.951 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.810949e-01 | 0.742 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.712983e-01 | 0.766 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.169959e-01 | 0.664 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.982012e-01 | 0.703 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.300818e-01 | 0.886 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.946274e-01 | 0.711 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.390149e-01 | 0.857 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 2.007508e-01 | 0.697 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.246125e-01 | 0.904 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 2.098449e-01 | 0.678 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.126388e-01 | 0.948 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.712983e-01 | 0.766 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 1.252297e-01 | 0.902 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 1.240668e-01 | 0.906 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.282849e-01 | 0.892 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.252887e-01 | 0.902 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.423193e-01 | 0.847 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.240668e-01 | 0.906 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 1.517195e-01 | 0.819 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 1.419880e-01 | 0.848 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 2.050122e-01 | 0.688 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 2.050122e-01 | 0.688 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.363167e-01 | 0.865 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.112103e-01 | 0.954 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 1.329320e-01 | 0.876 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 2.098449e-01 | 0.678 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.517195e-01 | 0.819 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.712983e-01 | 0.766 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.688835e-01 | 0.772 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.024288e-01 | 0.694 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.236630e-01 | 0.908 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.650140e-01 | 0.782 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 2.159824e-01 | 0.666 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.159824e-01 | 0.666 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.246125e-01 | 0.904 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.662537e-01 | 0.779 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.662537e-01 | 0.779 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 2.098449e-01 | 0.678 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.126388e-01 | 0.948 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 1.332568e-01 | 0.875 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.810949e-01 | 0.742 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.552821e-01 | 0.809 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.251291e-01 | 0.903 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.390149e-01 | 0.857 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.916067e-01 | 0.718 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.022763e-01 | 0.694 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 1.119863e-01 | 0.951 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.583319e-01 | 0.800 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 2.003331e-01 | 0.698 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 1.251291e-01 | 0.903 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.810949e-01 | 0.742 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.810949e-01 | 0.742 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 2.019479e-01 | 0.695 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 1.688835e-01 | 0.772 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.811001e-01 | 0.742 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.195110e-01 | 0.923 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.240668e-01 | 0.906 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.517195e-01 | 0.819 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 1.318368e-01 | 0.880 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.363167e-01 | 0.865 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.118839e-01 | 0.674 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 1.385846e-01 | 0.858 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 1.247185e-01 | 0.904 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.138664e-01 | 0.944 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 2.098449e-01 | 0.678 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 1.332568e-01 | 0.875 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 1.332568e-01 | 0.875 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.810949e-01 | 0.742 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.810949e-01 | 0.742 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.127120e-01 | 0.672 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 1.518867e-01 | 0.818 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.151144e-01 | 0.939 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.300818e-01 | 0.886 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.127120e-01 | 0.672 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 1.518244e-01 | 0.819 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 1.785525e-01 | 0.748 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.518244e-01 | 0.819 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 2.127120e-01 | 0.672 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.421704e-01 | 0.847 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 1.332568e-01 | 0.875 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 1.332568e-01 | 0.875 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.161245e-01 | 0.935 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.857809e-01 | 0.731 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 1.916067e-01 | 0.718 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 1.847890e-01 | 0.733 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.536119e-01 | 0.814 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.022763e-01 | 0.694 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.916067e-01 | 0.718 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 2.098449e-01 | 0.678 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 2.183211e-01 | 0.661 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.210378e-01 | 0.656 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.246911e-01 | 0.648 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.247086e-01 | 0.648 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.247086e-01 | 0.648 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.281465e-01 | 0.642 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.281465e-01 | 0.642 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.281465e-01 | 0.642 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.281465e-01 | 0.642 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 2.281465e-01 | 0.642 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.300369e-01 | 0.638 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 2.313229e-01 | 0.636 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.314008e-01 | 0.636 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 2.314008e-01 | 0.636 | 0 | 0 |
| Disease | R-HSA-1643685 | 2.324988e-01 | 0.634 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.339903e-01 | 0.631 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 2.345107e-01 | 0.630 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.345107e-01 | 0.630 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 2.358505e-01 | 0.627 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.358505e-01 | 0.627 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.363630e-01 | 0.626 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.363630e-01 | 0.626 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.380267e-01 | 0.623 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.426153e-01 | 0.615 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.448092e-01 | 0.611 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 2.464511e-01 | 0.608 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.465667e-01 | 0.608 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.482235e-01 | 0.605 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 2.497175e-01 | 0.603 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 2.541242e-01 | 0.595 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 2.541242e-01 | 0.595 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.543935e-01 | 0.594 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.543935e-01 | 0.594 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 2.543935e-01 | 0.594 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.543935e-01 | 0.594 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.543935e-01 | 0.594 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 2.543935e-01 | 0.594 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.543935e-01 | 0.594 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.562309e-01 | 0.591 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 2.562309e-01 | 0.591 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.568974e-01 | 0.590 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 2.568976e-01 | 0.590 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 2.568976e-01 | 0.590 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 2.593257e-01 | 0.586 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.593257e-01 | 0.586 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.593257e-01 | 0.586 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.593257e-01 | 0.586 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 2.593622e-01 | 0.586 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 2.621394e-01 | 0.581 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 2.721778e-01 | 0.565 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 2.760109e-01 | 0.559 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.760109e-01 | 0.559 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 2.760109e-01 | 0.559 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.774511e-01 | 0.557 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.791815e-01 | 0.554 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.791815e-01 | 0.554 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.797669e-01 | 0.553 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.806622e-01 | 0.552 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 2.806622e-01 | 0.552 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 2.806622e-01 | 0.552 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 2.816161e-01 | 0.550 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 2.816161e-01 | 0.550 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 2.816161e-01 | 0.550 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 2.844245e-01 | 0.546 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.908685e-01 | 0.536 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.913338e-01 | 0.536 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 2.971783e-01 | 0.527 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 2.974173e-01 | 0.527 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.991086e-01 | 0.524 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.991086e-01 | 0.524 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.991086e-01 | 0.524 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 2.991086e-01 | 0.524 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 2.991086e-01 | 0.524 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.991086e-01 | 0.524 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 2.991086e-01 | 0.524 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 2.991086e-01 | 0.524 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.991086e-01 | 0.524 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.991086e-01 | 0.524 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 3.018350e-01 | 0.520 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.020353e-01 | 0.520 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.054116e-01 | 0.515 | 0 | 0 |
| Abasic sugar-phosphate removal via the single-nucleotide replacement pathway | R-HSA-73930 | 3.058013e-01 | 0.515 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.058013e-01 | 0.515 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.058013e-01 | 0.515 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.058013e-01 | 0.515 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.058013e-01 | 0.515 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.058013e-01 | 0.515 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.058013e-01 | 0.515 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.058013e-01 | 0.515 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.058013e-01 | 0.515 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.058013e-01 | 0.515 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.058013e-01 | 0.515 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.058013e-01 | 0.515 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.058013e-01 | 0.515 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.058013e-01 | 0.515 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 3.058013e-01 | 0.515 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.058013e-01 | 0.515 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.075966e-01 | 0.512 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.075966e-01 | 0.512 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.075966e-01 | 0.512 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.075966e-01 | 0.512 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.075966e-01 | 0.512 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.075966e-01 | 0.512 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 3.075966e-01 | 0.512 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.088233e-01 | 0.510 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.088308e-01 | 0.510 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.088308e-01 | 0.510 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 3.088308e-01 | 0.510 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 3.088308e-01 | 0.510 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.088308e-01 | 0.510 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 3.088308e-01 | 0.510 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.098383e-01 | 0.509 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.145502e-01 | 0.502 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.181120e-01 | 0.497 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.181120e-01 | 0.497 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.194745e-01 | 0.496 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 3.265369e-01 | 0.486 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.265369e-01 | 0.486 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.265369e-01 | 0.486 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.290329e-01 | 0.483 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.290329e-01 | 0.483 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.373006e-01 | 0.472 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.392567e-01 | 0.469 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 3.392567e-01 | 0.469 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.392567e-01 | 0.469 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 3.395284e-01 | 0.469 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.417654e-01 | 0.466 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.417654e-01 | 0.466 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 3.417654e-01 | 0.466 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.433679e-01 | 0.464 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 3.433679e-01 | 0.464 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.433679e-01 | 0.464 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.433679e-01 | 0.464 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.433679e-01 | 0.464 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 3.433679e-01 | 0.464 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.433679e-01 | 0.464 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.433679e-01 | 0.464 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 3.433679e-01 | 0.464 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 3.483986e-01 | 0.458 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 3.483986e-01 | 0.458 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 3.483986e-01 | 0.458 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.502362e-01 | 0.456 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.504972e-01 | 0.455 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.555618e-01 | 0.449 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.566576e-01 | 0.448 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 3.605422e-01 | 0.443 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.620405e-01 | 0.441 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 3.620405e-01 | 0.441 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 3.662579e-01 | 0.436 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 3.733445e-01 | 0.428 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.740170e-01 | 0.427 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 3.740170e-01 | 0.427 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 3.740170e-01 | 0.427 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 3.741003e-01 | 0.427 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 3.745726e-01 | 0.426 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.745726e-01 | 0.426 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.745726e-01 | 0.426 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 3.745726e-01 | 0.426 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.812184e-01 | 0.419 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 3.819008e-01 | 0.418 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.853350e-01 | 0.414 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.853350e-01 | 0.414 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 3.853350e-01 | 0.414 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.853350e-01 | 0.414 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.853350e-01 | 0.414 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.853350e-01 | 0.414 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.853350e-01 | 0.414 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.853350e-01 | 0.414 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.853350e-01 | 0.414 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 3.853350e-01 | 0.414 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 3.853350e-01 | 0.414 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.866892e-01 | 0.413 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.866892e-01 | 0.413 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 3.866892e-01 | 0.413 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 3.866892e-01 | 0.413 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.866892e-01 | 0.413 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.866892e-01 | 0.413 | 0 | 0 |
| RSK activation | R-HSA-444257 | 3.866892e-01 | 0.413 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.874337e-01 | 0.412 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 3.874337e-01 | 0.412 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.892668e-01 | 0.410 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 3.892668e-01 | 0.410 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.892668e-01 | 0.410 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.914610e-01 | 0.407 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 3.936427e-01 | 0.405 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 3.977892e-01 | 0.400 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.977892e-01 | 0.400 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.986547e-01 | 0.399 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.020115e-01 | 0.396 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 4.035259e-01 | 0.394 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 4.070016e-01 | 0.390 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 4.070016e-01 | 0.390 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.070393e-01 | 0.390 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 4.070393e-01 | 0.390 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.163251e-01 | 0.381 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.214680e-01 | 0.375 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.214680e-01 | 0.375 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.221338e-01 | 0.375 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 4.245797e-01 | 0.372 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.267724e-01 | 0.370 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.287068e-01 | 0.368 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.287068e-01 | 0.368 | 0 | 0 |
| Hypusine synthesis from eIF5A-lysine | R-HSA-204626 | 4.287068e-01 | 0.368 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 4.287068e-01 | 0.368 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 4.287068e-01 | 0.368 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 4.287068e-01 | 0.368 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.287068e-01 | 0.368 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 4.287068e-01 | 0.368 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.287068e-01 | 0.368 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 4.287068e-01 | 0.368 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 4.291778e-01 | 0.367 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.382098e-01 | 0.358 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 4.389814e-01 | 0.358 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 4.389814e-01 | 0.358 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.389814e-01 | 0.358 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 4.389814e-01 | 0.358 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 4.389814e-01 | 0.358 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.389814e-01 | 0.358 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.414647e-01 | 0.355 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.414647e-01 | 0.355 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 4.431017e-01 | 0.353 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.459983e-01 | 0.351 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.519672e-01 | 0.345 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.519672e-01 | 0.345 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.557607e-01 | 0.341 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.557607e-01 | 0.341 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.557607e-01 | 0.341 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.557607e-01 | 0.341 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.557607e-01 | 0.341 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.557607e-01 | 0.341 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 4.557607e-01 | 0.341 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.557607e-01 | 0.341 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 4.557607e-01 | 0.341 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 4.624143e-01 | 0.335 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 4.668103e-01 | 0.331 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.668103e-01 | 0.331 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.690158e-01 | 0.329 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.691508e-01 | 0.329 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 4.691508e-01 | 0.329 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 4.691508e-01 | 0.329 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.691508e-01 | 0.329 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 4.691508e-01 | 0.329 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.691508e-01 | 0.329 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.691508e-01 | 0.329 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.694942e-01 | 0.328 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.694942e-01 | 0.328 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 4.702419e-01 | 0.328 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 4.702419e-01 | 0.328 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 4.702419e-01 | 0.328 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 4.702419e-01 | 0.328 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 4.702419e-01 | 0.328 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 4.702419e-01 | 0.328 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 4.702419e-01 | 0.328 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 4.780962e-01 | 0.320 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.792215e-01 | 0.319 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 4.845149e-01 | 0.315 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 4.845149e-01 | 0.315 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 4.845149e-01 | 0.315 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.845149e-01 | 0.315 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.871365e-01 | 0.312 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.876218e-01 | 0.312 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 4.876218e-01 | 0.312 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.876218e-01 | 0.312 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.876218e-01 | 0.312 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.881734e-01 | 0.311 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.881734e-01 | 0.311 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 4.954120e-01 | 0.305 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.954120e-01 | 0.305 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.984195e-01 | 0.302 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 5.000918e-01 | 0.301 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.006897e-01 | 0.300 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 5.006897e-01 | 0.300 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.065178e-01 | 0.295 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.078303e-01 | 0.294 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.078303e-01 | 0.294 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.078303e-01 | 0.294 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.078303e-01 | 0.294 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.078303e-01 | 0.294 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.078303e-01 | 0.294 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 5.078303e-01 | 0.294 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.122338e-01 | 0.291 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 5.181209e-01 | 0.286 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.181209e-01 | 0.286 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.181209e-01 | 0.286 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 5.181209e-01 | 0.286 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.181209e-01 | 0.286 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 5.181209e-01 | 0.286 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 5.181209e-01 | 0.286 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.181209e-01 | 0.286 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.181209e-01 | 0.286 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 5.181209e-01 | 0.286 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 5.181209e-01 | 0.286 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.181209e-01 | 0.286 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 5.181209e-01 | 0.286 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.181209e-01 | 0.286 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.181209e-01 | 0.286 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.181209e-01 | 0.286 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.181209e-01 | 0.286 | 0 | 0 |
| Toxicity of tetanus toxin (tetX) | R-HSA-5250982 | 5.181209e-01 | 0.286 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 5.207757e-01 | 0.283 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.302174e-01 | 0.276 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 5.357355e-01 | 0.271 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 5.357355e-01 | 0.271 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 5.357355e-01 | 0.271 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.393334e-01 | 0.268 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 5.446189e-01 | 0.264 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.446189e-01 | 0.264 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 5.446189e-01 | 0.264 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.446189e-01 | 0.264 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.446189e-01 | 0.264 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.446189e-01 | 0.264 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.446189e-01 | 0.264 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 5.545354e-01 | 0.256 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.575899e-01 | 0.254 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.575899e-01 | 0.254 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.575899e-01 | 0.254 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.575899e-01 | 0.254 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.575899e-01 | 0.254 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.581956e-01 | 0.253 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.587396e-01 | 0.253 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 5.587396e-01 | 0.253 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 5.587396e-01 | 0.253 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.587396e-01 | 0.253 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 5.588739e-01 | 0.253 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.682172e-01 | 0.245 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.695377e-01 | 0.244 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 5.695783e-01 | 0.244 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.703662e-01 | 0.244 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 5.712644e-01 | 0.243 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.733390e-01 | 0.242 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.733390e-01 | 0.242 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.733390e-01 | 0.242 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.733390e-01 | 0.242 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.733390e-01 | 0.242 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.733390e-01 | 0.242 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.733390e-01 | 0.242 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.733390e-01 | 0.242 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.733390e-01 | 0.242 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.733390e-01 | 0.242 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.733390e-01 | 0.242 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 5.733390e-01 | 0.242 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.733390e-01 | 0.242 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.733390e-01 | 0.242 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.733390e-01 | 0.242 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.733390e-01 | 0.242 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.733390e-01 | 0.242 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.767169e-01 | 0.239 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 5.787511e-01 | 0.238 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.787511e-01 | 0.238 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.794419e-01 | 0.237 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.794419e-01 | 0.237 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.794419e-01 | 0.237 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.794419e-01 | 0.237 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.794419e-01 | 0.237 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.794419e-01 | 0.237 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 5.861906e-01 | 0.232 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.861906e-01 | 0.232 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 5.861906e-01 | 0.232 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.929115e-01 | 0.227 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.929115e-01 | 0.227 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.942072e-01 | 0.226 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.988780e-01 | 0.223 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 5.993608e-01 | 0.222 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 5.993608e-01 | 0.222 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.037005e-01 | 0.219 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.052185e-01 | 0.218 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.122669e-01 | 0.213 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.122669e-01 | 0.213 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.122669e-01 | 0.213 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.122669e-01 | 0.213 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 6.125224e-01 | 0.213 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 6.125224e-01 | 0.213 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 6.154781e-01 | 0.211 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.168717e-01 | 0.210 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.187770e-01 | 0.208 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.222326e-01 | 0.206 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.222326e-01 | 0.206 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.222326e-01 | 0.206 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.222326e-01 | 0.206 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.222326e-01 | 0.206 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 6.222326e-01 | 0.206 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.222326e-01 | 0.206 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 6.222326e-01 | 0.206 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.222326e-01 | 0.206 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.222326e-01 | 0.206 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.222326e-01 | 0.206 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.222326e-01 | 0.206 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 6.222326e-01 | 0.206 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.222326e-01 | 0.206 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.222326e-01 | 0.206 | 0 | 0 |
| Intestinal hexose absorption | R-HSA-8981373 | 6.222326e-01 | 0.206 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.222326e-01 | 0.206 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.222326e-01 | 0.206 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 6.222326e-01 | 0.206 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.222326e-01 | 0.206 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.222326e-01 | 0.206 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 6.222326e-01 | 0.206 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.222326e-01 | 0.206 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.236591e-01 | 0.205 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.273056e-01 | 0.203 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 6.280439e-01 | 0.202 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 6.367633e-01 | 0.196 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 6.367633e-01 | 0.196 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 6.372481e-01 | 0.196 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.372481e-01 | 0.196 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.377028e-01 | 0.195 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 6.377028e-01 | 0.195 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.388101e-01 | 0.195 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.430943e-01 | 0.192 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 6.430943e-01 | 0.192 | 0 | 0 |
| Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA | R-HSA-77310 | 6.430943e-01 | 0.192 | 0 | 0 |
| Beta oxidation of hexanoyl-CoA to butanoyl-CoA | R-HSA-77350 | 6.430943e-01 | 0.192 | 0 | 0 |
| Beta oxidation of octanoyl-CoA to hexanoyl-CoA | R-HSA-77348 | 6.430943e-01 | 0.192 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.430943e-01 | 0.192 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 6.430943e-01 | 0.192 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.430943e-01 | 0.192 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 6.476333e-01 | 0.189 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 6.576051e-01 | 0.182 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 6.581995e-01 | 0.182 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.617134e-01 | 0.179 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 6.617134e-01 | 0.179 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 6.617134e-01 | 0.179 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.617134e-01 | 0.179 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.655257e-01 | 0.177 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.655257e-01 | 0.177 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.655257e-01 | 0.177 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.655257e-01 | 0.177 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.655257e-01 | 0.177 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 6.655257e-01 | 0.177 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 6.655257e-01 | 0.177 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.719510e-01 | 0.173 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.719510e-01 | 0.173 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 6.719510e-01 | 0.173 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.719510e-01 | 0.173 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 6.719510e-01 | 0.173 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.845479e-01 | 0.165 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.845479e-01 | 0.165 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.845479e-01 | 0.165 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.906503e-01 | 0.161 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 6.906829e-01 | 0.161 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.912681e-01 | 0.160 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 6.938253e-01 | 0.159 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 6.975942e-01 | 0.156 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.975942e-01 | 0.156 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.988836e-01 | 0.156 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.988836e-01 | 0.156 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.988836e-01 | 0.156 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 6.988836e-01 | 0.156 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.038595e-01 | 0.153 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 7.038595e-01 | 0.153 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 7.038595e-01 | 0.153 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 7.038595e-01 | 0.153 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 7.038595e-01 | 0.153 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.038595e-01 | 0.153 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 7.038595e-01 | 0.153 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 7.038595e-01 | 0.153 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.038595e-01 | 0.153 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 7.038595e-01 | 0.153 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 7.038595e-01 | 0.153 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 7.048499e-01 | 0.152 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.052268e-01 | 0.152 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.055380e-01 | 0.151 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.062102e-01 | 0.151 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.062102e-01 | 0.151 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 7.062102e-01 | 0.151 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.068468e-01 | 0.151 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.174345e-01 | 0.144 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 7.193103e-01 | 0.143 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 7.193103e-01 | 0.143 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 7.239541e-01 | 0.140 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.239541e-01 | 0.140 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.239541e-01 | 0.140 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 7.239541e-01 | 0.140 | 0 | 0 |
| Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA | R-HSA-77346 | 7.239541e-01 | 0.140 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.239541e-01 | 0.140 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 7.239541e-01 | 0.140 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.239541e-01 | 0.140 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 7.239541e-01 | 0.140 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 7.239541e-01 | 0.140 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.239541e-01 | 0.140 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 7.262844e-01 | 0.139 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 7.262844e-01 | 0.139 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.267131e-01 | 0.139 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.267131e-01 | 0.139 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.267131e-01 | 0.139 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 7.267131e-01 | 0.139 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.267131e-01 | 0.139 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.363715e-01 | 0.133 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.378019e-01 | 0.132 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.378019e-01 | 0.132 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.378019e-01 | 0.132 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.378019e-01 | 0.132 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 7.378019e-01 | 0.132 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.378019e-01 | 0.132 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.378019e-01 | 0.132 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.378019e-01 | 0.132 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.378019e-01 | 0.132 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 7.378019e-01 | 0.132 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.378019e-01 | 0.132 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.378019e-01 | 0.132 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.378019e-01 | 0.132 | 0 | 0 |
| Intestinal absorption | R-HSA-8963676 | 7.378019e-01 | 0.132 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 7.378019e-01 | 0.132 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.460769e-01 | 0.127 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 7.460769e-01 | 0.127 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 7.460769e-01 | 0.127 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.460769e-01 | 0.127 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 7.472356e-01 | 0.127 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 7.472356e-01 | 0.127 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 7.472356e-01 | 0.127 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.472356e-01 | 0.127 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.472356e-01 | 0.127 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.472356e-01 | 0.127 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.533314e-01 | 0.123 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.566674e-01 | 0.121 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 7.602297e-01 | 0.119 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.643277e-01 | 0.117 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 7.643277e-01 | 0.117 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.663139e-01 | 0.116 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.678558e-01 | 0.115 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.678558e-01 | 0.115 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.678558e-01 | 0.115 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.678558e-01 | 0.115 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.678558e-01 | 0.115 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.678558e-01 | 0.115 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.678558e-01 | 0.115 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.678558e-01 | 0.115 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.678558e-01 | 0.115 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.678558e-01 | 0.115 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.678558e-01 | 0.115 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.678558e-01 | 0.115 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.678558e-01 | 0.115 | 0 | 0 |
| PKA activation | R-HSA-163615 | 7.688086e-01 | 0.114 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.688086e-01 | 0.114 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 7.688086e-01 | 0.114 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.688086e-01 | 0.114 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.697416e-01 | 0.114 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.708932e-01 | 0.113 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 7.814970e-01 | 0.107 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 7.883421e-01 | 0.103 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 7.887588e-01 | 0.103 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 7.887588e-01 | 0.103 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.887588e-01 | 0.103 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.887588e-01 | 0.103 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.887588e-01 | 0.103 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.923467e-01 | 0.101 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.944663e-01 | 0.100 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.944663e-01 | 0.100 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.944663e-01 | 0.100 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.944663e-01 | 0.100 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.944663e-01 | 0.100 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.944663e-01 | 0.100 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.944663e-01 | 0.100 | 0 | 0 |
| Sperm Motility And Taxes | R-HSA-1300642 | 7.944663e-01 | 0.100 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.944663e-01 | 0.100 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 7.944663e-01 | 0.100 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.944663e-01 | 0.100 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.944663e-01 | 0.100 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 7.944663e-01 | 0.100 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 7.957849e-01 | 0.099 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.976198e-01 | 0.098 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.976198e-01 | 0.098 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.017439e-01 | 0.096 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.037404e-01 | 0.095 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.071749e-01 | 0.093 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.071749e-01 | 0.093 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.071749e-01 | 0.093 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.071749e-01 | 0.093 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.071749e-01 | 0.093 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.071749e-01 | 0.093 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.108231e-01 | 0.091 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.127344e-01 | 0.090 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.127344e-01 | 0.090 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.127344e-01 | 0.090 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 8.127344e-01 | 0.090 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.136783e-01 | 0.090 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.180279e-01 | 0.087 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.180279e-01 | 0.087 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.180279e-01 | 0.087 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.180279e-01 | 0.087 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 8.180279e-01 | 0.087 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.180279e-01 | 0.087 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 8.180279e-01 | 0.087 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.180279e-01 | 0.087 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.180279e-01 | 0.087 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 8.180279e-01 | 0.087 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.221844e-01 | 0.085 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.221844e-01 | 0.085 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 8.227620e-01 | 0.085 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.227620e-01 | 0.085 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.241462e-01 | 0.084 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 8.241462e-01 | 0.084 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 8.241462e-01 | 0.084 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.241462e-01 | 0.084 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.241462e-01 | 0.084 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.241462e-01 | 0.084 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 8.241462e-01 | 0.084 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.268813e-01 | 0.083 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.330413e-01 | 0.079 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.330413e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.330413e-01 | 0.079 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.330413e-01 | 0.079 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.330413e-01 | 0.079 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.330413e-01 | 0.079 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.342894e-01 | 0.079 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 8.388896e-01 | 0.076 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.388896e-01 | 0.076 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 8.388896e-01 | 0.076 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.388896e-01 | 0.076 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.388896e-01 | 0.076 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.388896e-01 | 0.076 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.388896e-01 | 0.076 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.397619e-01 | 0.076 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.397619e-01 | 0.076 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.397619e-01 | 0.076 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.401024e-01 | 0.076 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 8.446511e-01 | 0.073 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 8.446511e-01 | 0.073 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.456979e-01 | 0.073 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.456979e-01 | 0.073 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.524407e-01 | 0.069 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.541098e-01 | 0.068 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 8.541098e-01 | 0.068 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.541098e-01 | 0.068 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.541098e-01 | 0.068 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.541098e-01 | 0.068 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 8.541098e-01 | 0.068 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 8.564362e-01 | 0.067 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 8.564362e-01 | 0.067 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.564362e-01 | 0.067 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.572699e-01 | 0.067 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.573608e-01 | 0.067 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.573608e-01 | 0.067 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.573608e-01 | 0.067 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.573608e-01 | 0.067 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.573608e-01 | 0.067 | 0 | 0 |
| Beta oxidation of myristoyl-CoA to lauroyl-CoA | R-HSA-77285 | 8.573608e-01 | 0.067 | 0 | 0 |
| Beta oxidation of palmitoyl-CoA to myristoyl-CoA | R-HSA-77305 | 8.573608e-01 | 0.067 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.573608e-01 | 0.067 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.573608e-01 | 0.067 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 8.573608e-01 | 0.067 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.573608e-01 | 0.067 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.573608e-01 | 0.067 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.573608e-01 | 0.067 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.573608e-01 | 0.067 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.573608e-01 | 0.067 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 8.573608e-01 | 0.067 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.573608e-01 | 0.067 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.573608e-01 | 0.067 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 8.610291e-01 | 0.065 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.620311e-01 | 0.064 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.625549e-01 | 0.064 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 8.639394e-01 | 0.064 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.643687e-01 | 0.063 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.672751e-01 | 0.062 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.672751e-01 | 0.062 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 8.707696e-01 | 0.060 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 8.736093e-01 | 0.059 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 8.737153e-01 | 0.059 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.737153e-01 | 0.059 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.737153e-01 | 0.059 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.737153e-01 | 0.059 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 8.766619e-01 | 0.057 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.793405e-01 | 0.056 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.793405e-01 | 0.056 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.793405e-01 | 0.056 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 8.793405e-01 | 0.056 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.845912e-01 | 0.053 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.845912e-01 | 0.053 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.849009e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.881955e-01 | 0.051 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.881955e-01 | 0.051 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.881955e-01 | 0.051 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.881955e-01 | 0.051 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.881955e-01 | 0.051 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.881955e-01 | 0.051 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.881955e-01 | 0.051 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.881955e-01 | 0.051 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 8.899915e-01 | 0.051 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.903849e-01 | 0.050 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 8.919491e-01 | 0.050 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 8.921914e-01 | 0.050 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.921914e-01 | 0.050 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.938293e-01 | 0.049 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.938293e-01 | 0.049 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 8.954230e-01 | 0.048 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 8.977309e-01 | 0.047 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.004839e-01 | 0.046 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.004839e-01 | 0.046 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.004839e-01 | 0.046 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.004839e-01 | 0.046 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.004839e-01 | 0.046 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 9.010160e-01 | 0.045 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 9.010160e-01 | 0.045 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.010160e-01 | 0.045 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.010160e-01 | 0.045 | 0 | 0 |
| Beta oxidation of butanoyl-CoA to acetyl-CoA | R-HSA-77352 | 9.010160e-01 | 0.045 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 9.010160e-01 | 0.045 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.010160e-01 | 0.045 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.010160e-01 | 0.045 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 9.010160e-01 | 0.045 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.023976e-01 | 0.045 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.083141e-01 | 0.042 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.097090e-01 | 0.041 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.097090e-01 | 0.041 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.097090e-01 | 0.041 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.103362e-01 | 0.041 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.103362e-01 | 0.041 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 9.123671e-01 | 0.040 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.123671e-01 | 0.040 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.123671e-01 | 0.040 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 9.123671e-01 | 0.040 | 0 | 0 |
| Activation of the phototransduction cascade | R-HSA-2485179 | 9.123671e-01 | 0.040 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.123671e-01 | 0.040 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 9.123671e-01 | 0.040 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 9.123671e-01 | 0.040 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 9.123671e-01 | 0.040 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 9.123671e-01 | 0.040 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.168407e-01 | 0.038 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 9.176838e-01 | 0.037 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 9.181278e-01 | 0.037 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.181278e-01 | 0.037 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.212591e-01 | 0.036 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.214740e-01 | 0.036 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 9.224171e-01 | 0.035 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.224171e-01 | 0.035 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of unsaturated fatty acids | R-HSA-77288 | 9.224171e-01 | 0.035 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.224171e-01 | 0.035 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.244779e-01 | 0.034 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.244779e-01 | 0.034 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.258038e-01 | 0.033 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.265533e-01 | 0.033 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.267634e-01 | 0.033 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.267634e-01 | 0.033 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.267634e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.275208e-01 | 0.033 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.307543e-01 | 0.031 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.313151e-01 | 0.031 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.313151e-01 | 0.031 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.313151e-01 | 0.031 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.313151e-01 | 0.031 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 9.313151e-01 | 0.031 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.318548e-01 | 0.031 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.319228e-01 | 0.031 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.327966e-01 | 0.030 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.335931e-01 | 0.030 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.365472e-01 | 0.028 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.365472e-01 | 0.028 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.367177e-01 | 0.028 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.367548e-01 | 0.028 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.380465e-01 | 0.028 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.391619e-01 | 0.027 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.391930e-01 | 0.027 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.391930e-01 | 0.027 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.391930e-01 | 0.027 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 9.391930e-01 | 0.027 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.391930e-01 | 0.027 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.391930e-01 | 0.027 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.412768e-01 | 0.026 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.419087e-01 | 0.026 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.429887e-01 | 0.025 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.449517e-01 | 0.025 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.461677e-01 | 0.024 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 9.461677e-01 | 0.024 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 9.461677e-01 | 0.024 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.461677e-01 | 0.024 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.461677e-01 | 0.024 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.461677e-01 | 0.024 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.461677e-01 | 0.024 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.502142e-01 | 0.022 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.503657e-01 | 0.022 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.523428e-01 | 0.021 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.523428e-01 | 0.021 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.523428e-01 | 0.021 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.523428e-01 | 0.021 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 9.523428e-01 | 0.021 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.523428e-01 | 0.021 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.524468e-01 | 0.021 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 9.549941e-01 | 0.020 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.549941e-01 | 0.020 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.549941e-01 | 0.020 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.549941e-01 | 0.020 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.551954e-01 | 0.020 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.551954e-01 | 0.020 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.578099e-01 | 0.019 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.578099e-01 | 0.019 | 0 | 0 |
| Phenylalanine metabolism | R-HSA-8964208 | 9.578099e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.578099e-01 | 0.019 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.588164e-01 | 0.018 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.593329e-01 | 0.018 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.593329e-01 | 0.018 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.597977e-01 | 0.018 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.620187e-01 | 0.017 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.626501e-01 | 0.017 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.626501e-01 | 0.017 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.626501e-01 | 0.017 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.626501e-01 | 0.017 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.626501e-01 | 0.017 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.627884e-01 | 0.016 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.628670e-01 | 0.016 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.628670e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.632689e-01 | 0.016 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.632689e-01 | 0.016 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.644933e-01 | 0.016 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.650565e-01 | 0.015 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.650565e-01 | 0.015 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.669352e-01 | 0.015 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.669352e-01 | 0.015 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.669352e-01 | 0.015 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.669352e-01 | 0.015 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.678669e-01 | 0.014 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.681650e-01 | 0.014 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.690654e-01 | 0.014 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.700707e-01 | 0.013 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.705752e-01 | 0.013 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.707290e-01 | 0.013 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.707290e-01 | 0.013 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.707290e-01 | 0.013 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.707290e-01 | 0.013 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.707290e-01 | 0.013 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 9.707290e-01 | 0.013 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.711513e-01 | 0.013 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.713620e-01 | 0.013 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.728153e-01 | 0.012 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.740876e-01 | 0.011 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.740876e-01 | 0.011 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.740876e-01 | 0.011 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.740876e-01 | 0.011 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.742760e-01 | 0.011 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.747192e-01 | 0.011 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.770611e-01 | 0.010 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.770611e-01 | 0.010 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.770611e-01 | 0.010 | 0 | 0 |
| Fertilization | R-HSA-1187000 | 9.770611e-01 | 0.010 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.796935e-01 | 0.009 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.796935e-01 | 0.009 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.796935e-01 | 0.009 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.796935e-01 | 0.009 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.797533e-01 | 0.009 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.820239e-01 | 0.008 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.820239e-01 | 0.008 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.821760e-01 | 0.008 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.823022e-01 | 0.008 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.823580e-01 | 0.008 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.836301e-01 | 0.007 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.840870e-01 | 0.007 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.840870e-01 | 0.007 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.840870e-01 | 0.007 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.840870e-01 | 0.007 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 9.855462e-01 | 0.006 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.855462e-01 | 0.006 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.859135e-01 | 0.006 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.859135e-01 | 0.006 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.866396e-01 | 0.006 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.867673e-01 | 0.006 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.875304e-01 | 0.005 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.875304e-01 | 0.005 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.878993e-01 | 0.005 | 0 | 0 |
| mitochondrial fatty acid beta-oxidation of saturated fatty acids | R-HSA-77286 | 9.882929e-01 | 0.005 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.889618e-01 | 0.005 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.889618e-01 | 0.005 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.913507e-01 | 0.004 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.913507e-01 | 0.004 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.914834e-01 | 0.004 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.923437e-01 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.923437e-01 | 0.003 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.925348e-01 | 0.003 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.925348e-01 | 0.003 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.932228e-01 | 0.003 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.932228e-01 | 0.003 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.935779e-01 | 0.003 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.938599e-01 | 0.003 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.940010e-01 | 0.003 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.944340e-01 | 0.002 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.946898e-01 | 0.002 | 0 | 0 |
| Phenylalanine and tyrosine metabolism | R-HSA-8963691 | 9.952996e-01 | 0.002 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.952996e-01 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.952996e-01 | 0.002 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.953729e-01 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.958395e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.959342e-01 | 0.002 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.967390e-01 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.967403e-01 | 0.001 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.967403e-01 | 0.001 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.970957e-01 | 0.001 | 0 | 0 |
| Aflatoxin activation and detoxification | R-HSA-5423646 | 9.971147e-01 | 0.001 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.972079e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.972986e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.977699e-01 | 0.001 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.981424e-01 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.982291e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.982291e-01 | 0.001 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.983322e-01 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.984326e-01 | 0.001 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.987388e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.987721e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.989132e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.989743e-01 | 0.000 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.989907e-01 | 0.000 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.990381e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.990486e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.992209e-01 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.992465e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.993025e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.993025e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.995098e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.995526e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.995542e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.995903e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.995908e-01 | 0.000 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.996419e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.996797e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.996797e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.996797e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.997009e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.997164e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.997490e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997702e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.997710e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.997779e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.997779e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.997779e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.997845e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997874e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.998163e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.998260e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.998260e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.998833e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.998849e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999056e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999257e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999260e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999346e-01 | 0.000 | 0 | 0 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.999547e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999567e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999611e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999623e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999623e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999754e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999787e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999846e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999867e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999889e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999942e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999950e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999992e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999996e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999996e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000e+00 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |